Correlation between copy number variation genes (focal events) and selected clinical features

Overview

Introduction

This pipeline computes the correlation between significant copy number variation (cnv focal) genes and selected clinical features.

Summary

Testing the association between copy number variation 100 focal events and 7 clinical features across 528 patients, 443 significant findings detected with Q value < 0.25.

amp_1p35.2 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_1p34.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
amp_1p22.3 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'ETHNICITY'.
amp_1q21.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_1q22 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_1q44 cnv correlated to 'Time to Death' and 'YEARS_TO_BIRTH'.
amp_2p24.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
amp_2q13 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
amp_3p25.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
amp_3p14.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'RACE', and 'ETHNICITY'.
amp_3q26.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
amp_3q26.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
amp_4p16.3 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
amp_5p15.33 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
amp_5q35.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_6p24.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
amp_6p22.3 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
amp_6q25.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_7q31.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
amp_8p11.22 cnv correlated to 'Time to Death'.
amp_8p11.21 cnv correlated to 'Time to Death', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'COMPLETENESS_OF_RESECTION'.
amp_8q24.21 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
amp_8q24.21 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'COMPLETENESS_OF_RESECTION'.
amp_9p24.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'COMPLETENESS_OF_RESECTION', and 'ETHNICITY'.
amp_9q34.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_10q22.2 cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.
amp_11p11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
amp_11q13.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
amp_11q14.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
amp_12p12.1 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RACE', and 'ETHNICITY'.
amp_12q13.11 cnv correlated to 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
amp_12q13.2 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
amp_13q34 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
amp_14q24.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
amp_14q32.33 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
amp_15q26.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'COMPLETENESS_OF_RESECTION'.
amp_16p11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
amp_17q11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
amp_17q12 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_17q25.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_18p11.31 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
amp_18q11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
amp_19p13.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
amp_19q12 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_20p13 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
amp_20q11.21 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
amp_20q13.12 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
amp_20q13.33 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
amp_22q12.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
amp_xp11.23 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
amp_xq28 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
del_1p36.21 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
del_1p36.11 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'COMPLETENESS_OF_RESECTION'.
del_2p25.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
del_2q22.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
del_2q37.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
del_3p14.2 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RACE', and 'ETHNICITY'.
del_3q13.31 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
del_4p16.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
del_4p15.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
del_4q22.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'COMPLETENESS_OF_RESECTION'.
del_4q34.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
del_5q12.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
del_6q26 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
del_7p22.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
del_7q11.22 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
del_7q31.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
del_7q36.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
del_8p23.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
del_8p21.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
del_9p23 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
del_9q21.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
del_9q34.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
del_10q23.31 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
del_11p15.5 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
del_11q14.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'RACE', and 'ETHNICITY'.
del_11q25 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
del_12q23.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
del_12q24.33 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'COMPLETENESS_OF_RESECTION'.
del_13q11 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RADIATIONS_RADIATION_REGIMENINDICATION'.
del_13q14.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
del_14q13.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
del_15q15.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
del_15q23 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
del_16p13.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
del_16q21 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
del_16q22.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
del_16q23.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
del_17p13.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
del_17p11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
del_17q11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
del_17q21.31 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'ETHNICITY'.
del_18q21.2 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
del_18q23 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', 'RACE', and 'ETHNICITY'.
del_19p13.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', 'COMPLETENESS_OF_RESECTION', and 'RACE'.
del_19p12 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
del_19q13.43 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'COMPLETENESS_OF_RESECTION'.
del_20p12.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'COMPLETENESS_OF_RESECTION'.
del_22q13.32 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RADIATIONS_RADIATION_REGIMENINDICATION', and 'RACE'.
del_xp21.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'COMPLETENESS_OF_RESECTION', and 'RACE'.

Results

Overview of the results

Table 1. Get Full Table Overview of the association between significant copy number variation of 100 focal events and 7 clinical features. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, 443 significant findings detected.


		Clinical Features	Time to Death	YEARS TO BIRTH	HISTOLOGICAL TYPE	RADIATIONS RADIATION REGIMENINDICATION	COMPLETENESS OF RESECTION	RACE	ETHNICITY
	nCNV (%)	nWild-Type	logrank test	Wilcoxon-test	Fisher's exact test	Fisher's exact test	Fisher's exact test	Fisher's exact test	Fisher's exact test
del 18q23	95 (18%)	433	0.0051 (0.0141)	0.000443 (0.00168)	1e-05 (5.88e-05)	0.000482 (0.00181)	0.0122 (0.0291)	0.0608 (0.114)	0.149 (0.236)
amp 3p14 1	63 (12%)	465	0.00125 (0.00421)	0.00377 (0.011)	8e-05 (0.000397)	0.0476 (0.0932)	0.263 (0.368)	0.0109 (0.0264)	0.0802 (0.145)
amp 5p15 33	88 (17%)	440	0.000241 (0.001)	0.000107 (0.000504)	1e-05 (5.88e-05)	0.113 (0.191)	0.133 (0.22)	0.00247 (0.00758)	0.277 (0.384)
amp 18p11 31	94 (18%)	434	0.00693 (0.0177)	8.63e-05 (0.000422)	1e-05 (5.88e-05)	0.0204 (0.0451)	0.0266 (0.0567)	0.00112 (0.00385)	1 (1.00)
amp 20q11 21	149 (28%)	379	0.000289 (0.00116)	1.88e-08 (1.2e-06)	1e-05 (5.88e-05)	0.00612 (0.0161)	0.106 (0.182)	0.00654 (0.017)	0.542 (0.637)
amp 20q13 12	149 (28%)	379	0.00947 (0.0234)	1.34e-08 (1e-06)	1e-05 (5.88e-05)	0.00104 (0.00369)	0.0596 (0.112)	0.00522 (0.0143)	0.554 (0.648)
amp 20q13 33	150 (28%)	378	0.014 (0.0326)	3.51e-08 (1.75e-06)	1e-05 (5.88e-05)	0.00101 (0.00362)	0.0133 (0.0313)	0.0395 (0.0806)	1 (1.00)
amp 22q12 2	62 (12%)	466	0.000495 (0.00185)	0.000572 (0.00212)	1e-05 (5.88e-05)	0.0474 (0.0932)	0.00228 (0.00709)	0.0256 (0.0548)	0.675 (0.762)
del 2q22 1	46 (9%)	482	1.26e-07 (5.19e-06)	0.0048 (0.0134)	1e-05 (5.88e-05)	0.0027 (0.00814)	0.00162 (0.00525)	0.0849 (0.152)	1 (1.00)
del 2q37 3	52 (10%)	476	0.0185 (0.0413)	0.00257 (0.00787)	0.0001 (0.000473)	0.137 (0.223)	0.0439 (0.0871)	0.142 (0.228)	1 (1.00)
del 4q34 3	127 (24%)	401	0.00667 (0.0172)	6.72e-07 (2.35e-05)	1e-05 (5.88e-05)	0.134 (0.221)	0.137 (0.224)	0.0115 (0.0277)	1 (1.00)
del 8p23 2	115 (22%)	413	0.000772 (0.00282)	2.17e-05 (0.00012)	1e-05 (5.88e-05)	0.122 (0.205)	0.0585 (0.111)	0.00564 (0.0151)	0.319 (0.422)
del 8p21 2	113 (21%)	415	0.00679 (0.0174)	2.6e-06 (5.88e-05)	1e-05 (5.88e-05)	0.151 (0.24)	0.146 (0.233)	0.00731 (0.0186)	0.743 (0.808)
del 11p15 5	102 (19%)	426	0.0163 (0.037)	1.22e-05 (6.98e-05)	1e-05 (5.88e-05)	0.00584 (0.0155)	0.0897 (0.159)	0.0548 (0.105)	0.498 (0.593)
del 11q14 1	70 (13%)	458	0.0903 (0.16)	0.000288 (0.00116)	1e-05 (5.88e-05)	0.0591 (0.112)	0.65 (0.738)	0.0717 (0.132)	0.0431 (0.0857)
del 12q23 1	53 (10%)	475	0.000179 (0.000803)	0.00236 (0.00727)	1e-05 (5.88e-05)	0.0491 (0.0956)	0.041 (0.083)	0.0413 (0.0831)	1 (1.00)
del 15q15 1	136 (26%)	392	7.04e-05 (0.000357)	2.37e-08 (1.38e-06)	1e-05 (5.88e-05)	0.0131 (0.0308)	0.0396 (0.0806)	0.0549 (0.105)	1 (1.00)
del 16p13 3	90 (17%)	438	0.00536 (0.0145)	2.2e-06 (5.88e-05)	1e-05 (5.88e-05)	0.0682 (0.127)	0.105 (0.181)	0.0297 (0.0618)	1 (1.00)
del 17p13 3	119 (23%)	409	0.000112 (0.000522)	0.000232 (0.000974)	1e-05 (5.88e-05)	0.0451 (0.0889)	0.146 (0.233)	0.00155 (0.00507)	1 (1.00)
del 17q21 31	109 (21%)	419	0.000198 (0.000864)	1.18e-05 (6.85e-05)	1e-05 (5.88e-05)	0.0522 (0.101)	0.0707 (0.131)	0.174 (0.267)	0.0481 (0.094)
del 19p13 3	151 (29%)	377	7.09e-06 (5.88e-05)	1.35e-10 (4.73e-08)	1e-05 (5.88e-05)	0.0815 (0.147)	0.00614 (0.0161)	0.00027 (0.00111)	0.241 (0.343)
amp 1p34 2	72 (14%)	456	0.00499 (0.0138)	9.18e-05 (0.00044)	1e-05 (5.88e-05)	0.254 (0.358)	0.0924 (0.163)	0.0283 (0.0597)	0.698 (0.781)
amp 3p25 1	80 (15%)	448	0.031 (0.0639)	0.000276 (0.00113)	1e-05 (5.88e-05)	0.0992 (0.173)	0.695 (0.78)	0.00328 (0.00969)	0.47 (0.572)
amp 3q26 2	171 (32%)	357	0.000911 (0.00327)	2.54e-11 (1.78e-08)	1e-05 (5.88e-05)	0.0273 (0.0577)	0.306 (0.412)	2e-05 (0.000111)	0.563 (0.655)
amp 3q26 2	159 (30%)	369	0.00286 (0.00857)	3.3e-09 (4.62e-07)	1e-05 (5.88e-05)	0.0533 (0.103)	0.201 (0.298)	0.00015 (0.000686)	0.243 (0.345)
amp 8q24 21	212 (40%)	316	0.000397 (0.00152)	0.0149 (0.0343)	1e-05 (5.88e-05)	0.00359 (0.0105)	0.0114 (0.0276)	0.566 (0.658)	0.786 (0.84)
amp 9p24 2	64 (12%)	464	0.0302 (0.0625)	0.00194 (0.00614)	1e-05 (5.88e-05)	0.291 (0.396)	0.135 (0.222)	0.166 (0.26)	0.0214 (0.0472)
amp 11q14 1	56 (11%)	472	5.34e-07 (1.97e-05)	0.0108 (0.0263)	1e-05 (5.88e-05)	0.15 (0.237)	0.335 (0.44)	0.101 (0.176)	1 (1.00)
amp 12q13 2	97 (18%)	431	0.697 (0.78)	0.113 (0.192)	1e-05 (5.88e-05)	0.0561 (0.106)	0.124 (0.207)	0.124 (0.207)	0.745 (0.809)
amp 14q32 33	76 (14%)	452	0.00433 (0.0123)	0.00112 (0.00385)	1e-05 (5.88e-05)	0.00784 (0.0197)	0.401 (0.508)	0.0198 (0.0439)	0.703 (0.783)
amp 15q26 3	37 (7%)	491	0.00146 (0.00479)	0.00329 (0.00969)	9e-05 (0.000434)	0.081 (0.146)	0.0122 (0.0291)	0.787 (0.84)	0.346 (0.453)
amp 16p11 2	64 (12%)	464	0.0156 (0.0359)	0.000343 (0.00134)	1e-05 (5.88e-05)	0.451 (0.553)	0.0732 (0.135)	0.0954 (0.167)	0.692 (0.778)
amp 17q11 2	71 (13%)	457	0.00184 (0.00588)	0.00579 (0.0154)	1e-05 (5.88e-05)	0.313 (0.418)	0.00113 (0.00386)	0.00234 (0.00725)	0.404 (0.509)
amp 18q11 2	68 (13%)	460	0.00841 (0.021)	0.00197 (0.00623)	1e-05 (5.88e-05)	0.383 (0.49)	0.0755 (0.138)	0.00519 (0.0142)	1 (1.00)
amp 19p13 2	97 (18%)	431	0.0128 (0.0303)	4.56e-10 (9.41e-08)	1e-05 (5.88e-05)	0.0561 (0.106)	0.301 (0.408)	0.00133 (0.00443)	1 (1.00)
del 4q22 1	102 (19%)	426	0.00539 (0.0145)	8e-06 (5.88e-05)	1e-05 (5.88e-05)	0.135 (0.222)	0.0787 (0.144)	0.238 (0.34)	0.737 (0.806)
del 9p23	76 (14%)	452	0.0163 (0.037)	0.00143 (0.00473)	1e-05 (5.88e-05)	0.0491 (0.0956)	0.331 (0.436)	0.13 (0.215)	0.703 (0.783)
del 9q21 2	126 (24%)	402	1.41e-05 (8.05e-05)	5.38e-10 (9.41e-08)	1e-05 (5.88e-05)	0.135 (0.221)	0.173 (0.267)	0.0288 (0.0605)	0.751 (0.812)
del 11q25	92 (17%)	436	0.00906 (0.0224)	0.000253 (0.00105)	1e-05 (5.88e-05)	0.00266 (0.0081)	0.39 (0.497)	0.0842 (0.151)	0.725 (0.799)
del 12q24 33	63 (12%)	465	0.00562 (0.0151)	2.22e-05 (0.000121)	1e-05 (5.88e-05)	0.0219 (0.0481)	0.0267 (0.0567)	0.29 (0.396)	1 (1.00)
del 13q14 2	103 (20%)	425	0.00126 (0.00423)	0.00137 (0.00454)	1e-05 (5.88e-05)	0.009 (0.0223)	0.403 (0.509)	0.154 (0.243)	0.192 (0.291)
del 15q23	113 (21%)	415	0.0119 (0.0286)	8.57e-06 (5.88e-05)	1e-05 (5.88e-05)	0.0551 (0.105)	0.431 (0.534)	0.0338 (0.0691)	0.318 (0.422)
del 16q21	150 (28%)	378	0.00957 (0.0235)	1.31e-08 (1e-06)	1e-05 (5.88e-05)	0.082 (0.148)	0.23 (0.331)	0.0232 (0.0507)	0.765 (0.825)
del 16q23 1	162 (31%)	366	0.00282 (0.00847)	8.79e-09 (8.79e-07)	1e-05 (5.88e-05)	0.201 (0.298)	0.0173 (0.039)	0.00318 (0.00943)	1 (1.00)
del 17p11 2	124 (23%)	404	0.000381 (0.00148)	4.49e-06 (5.88e-05)	1e-05 (5.88e-05)	0.105 (0.182)	0.514 (0.611)	0.0125 (0.0296)	1 (1.00)
del 18q21 2	89 (17%)	439	0.427 (0.532)	0.0003 (0.0012)	1e-05 (5.88e-05)	0.00383 (0.0111)	0.129 (0.214)	0.0696 (0.13)	0.288 (0.395)
del 19p12	57 (11%)	471	0.0869 (0.155)	0.0143 (0.0332)	1e-05 (5.88e-05)	0.0256 (0.0548)	0.166 (0.26)	0.126 (0.21)	0.659 (0.746)
del 22q13 32	136 (26%)	392	0.000218 (0.000919)	1.05e-07 (4.59e-06)	1e-05 (5.88e-05)	0.0242 (0.0525)	0.288 (0.395)	0.0157 (0.0359)	0.224 (0.324)
del xp21 1	84 (16%)	444	1.97e-05 (0.000111)	0.000139 (0.00064)	1e-05 (5.88e-05)	0.178 (0.272)	0.125 (0.208)	0.00411 (0.0117)	0.254 (0.358)
amp 1q21 3	236 (45%)	292	0.0153 (0.0353)	5.3e-06 (5.88e-05)	2e-05 (0.000111)	0.237 (0.34)	0.647 (0.738)	0.00663 (0.0171)	0.276 (0.383)
amp 1q22	249 (47%)	279	0.000798 (0.00289)	4.65e-08 (2.17e-06)	1e-05 (5.88e-05)	0.431 (0.534)	0.284 (0.392)	0.0165 (0.0374)	0.42 (0.525)
amp 2p24 3	118 (22%)	410	6.26e-05 (0.000324)	0.0135 (0.0316)	1e-05 (5.88e-05)	0.0251 (0.0542)	0.723 (0.799)	0.433 (0.537)	0.203 (0.3)
amp 5q35 3	53 (10%)	475	0.00614 (0.0161)	0.000282 (0.00115)	1e-05 (5.88e-05)	0.194 (0.292)	0.522 (0.619)	0.0197 (0.0438)	0.388 (0.495)
amp 6p24 2	114 (22%)	414	0.0559 (0.106)	2.5e-06 (5.88e-05)	1e-05 (5.88e-05)	0.0937 (0.164)	0.733 (0.804)	0.162 (0.255)	0.744 (0.808)
amp 6p22 3	104 (20%)	424	0.352 (0.459)	0.000195 (0.000856)	1e-05 (5.88e-05)	0.108 (0.185)	0.553 (0.648)	0.00738 (0.0187)	0.484 (0.582)
amp 6q25 1	84 (16%)	444	0.0921 (0.163)	0.00172 (0.00555)	1e-05 (5.88e-05)	0.42 (0.525)	0.17 (0.264)	0.00526 (0.0143)	0.704 (0.783)
amp 7q31 2	90 (17%)	438	8.52e-07 (2.73e-05)	0.0795 (0.144)	7e-05 (0.000357)	0.0184 (0.0413)	0.45 (0.553)	0.764 (0.825)	0.482 (0.581)
amp 8p11 21	161 (30%)	367	1.13e-05 (6.56e-05)	0.918 (0.966)	1e-05 (5.88e-05)	0.019 (0.0423)	0.00642 (0.0168)	0.184 (0.28)	0.562 (0.655)
amp 8q24 21	206 (39%)	322	0.000217 (0.000919)	0.0412 (0.083)	1e-05 (5.88e-05)	0.00478 (0.0134)	0.199 (0.296)	0.159 (0.25)	0.418 (0.523)
amp 9q34 3	38 (7%)	490	0.0429 (0.0855)	0.00159 (0.00516)	1e-05 (5.88e-05)	0.708 (0.785)	0.557 (0.651)	0.00983 (0.0241)	0.612 (0.705)
amp 12p12 1	92 (17%)	436	0.95 (0.996)	0.145 (0.232)	1e-05 (5.88e-05)	0.299 (0.406)	0.634 (0.726)	0.117 (0.198)	0.145 (0.232)
amp 13q34	57 (11%)	471	0.526 (0.622)	8.49e-05 (0.000418)	1e-05 (5.88e-05)	0.874 (0.927)	0.0141 (0.0327)	0.0622 (0.116)	1 (1.00)
amp 17q12	74 (14%)	454	0.000384 (0.00148)	0.0027 (0.00814)	1e-05 (5.88e-05)	1 (1.00)	0.261 (0.367)	0.0053 (0.0144)	1 (1.00)
amp 17q25 1	102 (19%)	426	0.000212 (0.000903)	0.00112 (0.00385)	1e-05 (5.88e-05)	0.457 (0.558)	0.175 (0.268)	8e-05 (0.000397)	0.318 (0.422)
amp 19q12	116 (22%)	412	4.99e-05 (0.000265)	1.44e-08 (1e-06)	1e-05 (5.88e-05)	0.285 (0.393)	0.217 (0.316)	3e-05 (0.000162)	1 (1.00)
amp 20p13	116 (22%)	412	0.307 (0.412)	2.37e-06 (5.88e-05)	1e-05 (5.88e-05)	0.033 (0.0678)	0.518 (0.615)	0.0445 (0.088)	0.317 (0.422)
amp xp11 23	89 (17%)	439	0.0887 (0.158)	0.029 (0.0605)	0.00034 (0.00134)	0.025 (0.0541)	0.486 (0.584)	0.942 (0.988)	0.48 (0.58)
del 1p36 11	79 (15%)	449	0.00773 (0.0195)	9.85e-05 (0.000469)	1e-05 (5.88e-05)	0.49 (0.587)	0.0421 (0.0845)	0.344 (0.451)	0.247 (0.349)
del 2p25 3	26 (5%)	502	0.0429 (0.0855)	0.071 (0.132)	0.0104 (0.0254)	0.109 (0.185)	0.291 (0.396)	0.449 (0.553)	1 (1.00)
del 3p14 2	77 (15%)	451	0.264 (0.369)	0.00112 (0.00385)	1e-05 (5.88e-05)	0.264 (0.369)	0.774 (0.833)	0.022 (0.0482)	0.141 (0.228)
del 4p15 2	93 (18%)	435	0.00057 (0.00212)	7.19e-05 (0.000362)	1e-05 (5.88e-05)	0.0929 (0.163)	0.491 (0.587)	0.349 (0.455)	0.306 (0.412)
del 5q12 1	109 (21%)	419	0.00485 (0.0135)	6.11e-06 (5.88e-05)	1e-05 (5.88e-05)	0.227 (0.327)	0.705 (0.783)	0.0747 (0.137)	0.192 (0.291)
del 7p22 3	70 (13%)	458	0.00112 (0.00385)	6.52e-05 (0.000336)	1e-05 (5.88e-05)	0.472 (0.572)	0.274 (0.381)	0.119 (0.201)	0.692 (0.778)
del 7q31 1	53 (10%)	475	0.0267 (0.0567)	5.65e-05 (0.000295)	1e-05 (5.88e-05)	1 (1.00)	0.413 (0.518)	0.114 (0.192)	1 (1.00)
del 9q34 2	128 (24%)	400	0.000133 (0.000615)	2.65e-08 (1.42e-06)	1e-05 (5.88e-05)	0.109 (0.185)	0.21 (0.309)	0.159 (0.25)	1 (1.00)
del 10q23 31	75 (14%)	453	0.00423 (0.012)	0.000879 (0.00317)	1e-05 (5.88e-05)	0.00452 (0.0128)	0.221 (0.321)	0.319 (0.422)	1 (1.00)
del 13q11	94 (18%)	434	0.00311 (0.00928)	0.00111 (0.00385)	1e-05 (5.88e-05)	0.0397 (0.0806)	0.193 (0.291)	0.319 (0.422)	0.306 (0.412)
del 14q13 1	71 (13%)	457	0.00804 (0.0202)	0.00402 (0.0115)	1e-05 (5.88e-05)	0.471 (0.572)	1 (1.00)	0.00394 (0.0113)	0.409 (0.513)
del 16q22 3	154 (29%)	374	0.0289 (0.0605)	5.81e-09 (6.78e-07)	1e-05 (5.88e-05)	0.196 (0.293)	0.2 (0.298)	0.0323 (0.0665)	1 (1.00)
del 19q13 43	65 (12%)	463	0.00191 (0.00608)	0.000307 (0.00122)	1e-05 (5.88e-05)	0.37 (0.476)	0.0255 (0.0548)	0.191 (0.29)	0.232 (0.333)
del 20p12 1	35 (7%)	493	8.85e-05 (0.00043)	0.14 (0.228)	0.0002 (0.000864)	1 (1.00)	0.106 (0.182)	0.178 (0.272)	0.289 (0.396)
amp 1p35 2	55 (10%)	473	0.209 (0.307)	0.000173 (0.000783)	1e-05 (5.88e-05)	0.747 (0.81)	0.257 (0.361)	0.144 (0.231)	0.635 (0.727)
amp 1p22 3	95 (18%)	433	0.457 (0.558)	0.00124 (0.00421)	0.00018 (0.000803)	0.443 (0.548)	0.898 (0.947)	0.343 (0.451)	0.14 (0.227)
amp 2q13	116 (22%)	412	4.22e-05 (0.000225)	0.00032 (0.00126)	1e-05 (5.88e-05)	0.406 (0.511)	0.246 (0.349)	0.211 (0.309)	0.743 (0.808)
amp 11p11 2	50 (9%)	478	0.00175 (0.00563)	0.000211 (0.000903)	1e-05 (5.88e-05)	0.738 (0.806)	0.648 (0.738)	0.358 (0.465)	0.36 (0.465)
amp 11q13 2	70 (13%)	458	0.00465 (0.0131)	0.000622 (0.00228)	1e-05 (5.88e-05)	0.472 (0.572)	0.176 (0.269)	0.665 (0.752)	1 (1.00)
amp 12q13 11	84 (16%)	444	0.592 (0.685)	0.651 (0.738)	1e-05 (5.88e-05)	0.106 (0.182)	0.308 (0.413)	0.0178 (0.04)	0.482 (0.581)
amp 14q24 3	63 (12%)	465	0.000162 (0.000736)	0.00117 (0.00398)	1e-05 (5.88e-05)	0.172 (0.267)	0.388 (0.495)	0.399 (0.507)	0.681 (0.767)
amp xq28	89 (17%)	439	0.000466 (0.00176)	0.0513 (0.0994)	0.00059 (0.00217)	0.896 (0.946)	0.207 (0.304)	0.527 (0.622)	0.713 (0.789)
del 4p16 3	89 (17%)	439	0.00202 (0.00633)	0.000181 (0.000803)	1e-05 (5.88e-05)	0.359 (0.465)	0.855 (0.908)	0.31 (0.415)	0.728 (0.8)
del 7q36 1	62 (12%)	466	0.00848 (0.0211)	3.24e-07 (1.26e-05)	1e-05 (5.88e-05)	0.649 (0.738)	0.369 (0.476)	0.389 (0.495)	1 (1.00)
del 17q11 2	101 (19%)	427	0.0291 (0.0605)	8.58e-07 (2.73e-05)	1e-05 (5.88e-05)	0.169 (0.263)	0.23 (0.331)	0.777 (0.833)	0.737 (0.806)
amp 1q44	213 (40%)	315	0.0718 (0.132)	0.00104 (0.00369)	0.45 (0.553)	0.616 (0.707)	0.496 (0.592)	0.195 (0.293)	0.169 (0.263)
amp 4p16 3	52 (10%)	476	0.24 (0.342)	2.74e-05 (0.000149)	1e-05 (5.88e-05)	0.51 (0.607)	0.197 (0.294)	0.543 (0.638)	0.36 (0.465)
amp 10q22 2	143 (27%)	385	0.0931 (0.163)	0.213 (0.312)	0.00337 (0.00987)	0.378 (0.485)	0.447 (0.552)	0.575 (0.667)	0.766 (0.825)
del 1p36 21	69 (13%)	459	0.22 (0.32)	0.000199 (0.000864)	1e-05 (5.88e-05)	0.884 (0.937)	0.567 (0.658)	0.204 (0.302)	0.399 (0.507)
del 3q13 31	42 (8%)	486	0.776 (0.833)	0.000389 (0.0015)	1e-05 (5.88e-05)	0.28 (0.387)	0.823 (0.877)	0.784 (0.839)	1 (1.00)
del 6q26	45 (9%)	483	0.174 (0.267)	0.00651 (0.0169)	1e-05 (5.88e-05)	0.598 (0.69)	0.931 (0.978)	0.887 (0.938)	0.614 (0.706)
del 7q11 22	39 (7%)	489	0.987 (1.00)	5.17e-05 (0.000272)	1e-05 (5.88e-05)	0.708 (0.785)	0.607 (0.7)	0.464 (0.566)	1 (1.00)
amp 8p11 22	125 (24%)	403	0.00209 (0.00652)	0.217 (0.316)	0.828 (0.881)	0.355 (0.462)	0.727 (0.8)	0.292 (0.397)	0.532 (0.627)

'amp_1p35.2' versus 'YEARS_TO_BIRTH'

P value = 0.000173 (Wilcoxon-test), Q value = 0.00078

Table S1. Gene #1: 'amp_1p35.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 1(1P35.2) MUTATED	54	68.7 (8.8)
AMP PEAK 1(1P35.2) WILD-TYPE	472	63.5 (11.3)

Figure S1. Get High-res Image Gene #1: 'amp_1p35.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1p35.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S2. Gene #1: 'amp_1p35.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 1(1P35.2) MUTATED	16	5	34
AMP PEAK 1(1P35.2) WILD-TYPE	379	16	78

Figure S2. Get High-res Image Gene #1: 'amp_1p35.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_1p35.2' versus 'RACE'

P value = 0.144 (Fisher's exact test), Q value = 0.23

Table S3. Gene #1: 'amp_1p35.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 1(1P35.2) MUTATED	0	1	15	2	30
AMP PEAK 1(1P35.2) WILD-TYPE	4	19	86	7	336

Figure S3. Get High-res Image Gene #1: 'amp_1p35.2' versus Clinical Feature #6: 'RACE'

'amp_1p34.2' versus 'Time to Death'

P value = 0.00499 (logrank test), Q value = 0.014

Table S4. Gene #2: 'amp_1p34.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 2(1P34.2) MUTATED	72	17	0.1 - 125.4 (22.1)
AMP PEAK 2(1P34.2) WILD-TYPE	454	52	0.1 - 191.8 (23.4)

Figure S4. Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #1: 'Time to Death'

'amp_1p34.2' versus 'YEARS_TO_BIRTH'

P value = 9.18e-05 (Wilcoxon-test), Q value = 0.00044

Table S5. Gene #2: 'amp_1p34.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 2(1P34.2) MUTATED	71	68.6 (9.4)
AMP PEAK 2(1P34.2) WILD-TYPE	455	63.3 (11.3)

Figure S5. Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1p34.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S6. Gene #2: 'amp_1p34.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 2(1P34.2) MUTATED	21	7	44
AMP PEAK 2(1P34.2) WILD-TYPE	374	14	68

Figure S6. Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_1p34.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0924 (Fisher's exact test), Q value = 0.16

Table S7. Gene #2: 'amp_1p34.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
AMP PEAK 2(1P34.2) MUTATED	44	4	5	7
AMP PEAK 2(1P34.2) WILD-TYPE	319	19	12	28

Figure S7. Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_1p34.2' versus 'RACE'

P value = 0.0283 (Fisher's exact test), Q value = 0.06

Table S8. Gene #2: 'amp_1p34.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 2(1P34.2) MUTATED	0	1	22	2	39
AMP PEAK 2(1P34.2) WILD-TYPE	4	19	79	7	327

Figure S8. Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #6: 'RACE'

'amp_1p22.3' versus 'YEARS_TO_BIRTH'

P value = 0.00124 (Wilcoxon-test), Q value = 0.0042

Table S9. Gene #3: 'amp_1p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 3(1P22.3) MUTATED	95	67.2 (9.6)
AMP PEAK 3(1P22.3) WILD-TYPE	431	63.3 (11.4)

Figure S9. Get High-res Image Gene #3: 'amp_1p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1p22.3' versus 'HISTOLOGICAL_TYPE'

P value = 0.00018 (Fisher's exact test), Q value = 8e-04

Table S10. Gene #3: 'amp_1p22.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 3(1P22.3) MUTATED	55	5	35
AMP PEAK 3(1P22.3) WILD-TYPE	340	16	77

Figure S10. Get High-res Image Gene #3: 'amp_1p22.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_1p22.3' versus 'ETHNICITY'

P value = 0.14 (Fisher's exact test), Q value = 0.23

Table S11. Gene #3: 'amp_1p22.3' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	14	367
AMP PEAK 3(1P22.3) MUTATED	0	64
AMP PEAK 3(1P22.3) WILD-TYPE	14	303

Figure S11. Get High-res Image Gene #3: 'amp_1p22.3' versus Clinical Feature #7: 'ETHNICITY'

'amp_1q21.3' versus 'Time to Death'

P value = 0.0153 (logrank test), Q value = 0.035

Table S12. Gene #4: 'amp_1q21.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 4(1Q21.3) MUTATED	235	39	0.1 - 149.6 (20.8)
AMP PEAK 4(1Q21.3) WILD-TYPE	291	30	0.2 - 191.8 (24.3)

Figure S12. Get High-res Image Gene #4: 'amp_1q21.3' versus Clinical Feature #1: 'Time to Death'

'amp_1q21.3' versus 'YEARS_TO_BIRTH'

P value = 5.3e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S13. Gene #4: 'amp_1q21.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 4(1Q21.3) MUTATED	236	66.6 (10.3)
AMP PEAK 4(1Q21.3) WILD-TYPE	290	61.9 (11.5)

Figure S13. Get High-res Image Gene #4: 'amp_1q21.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1q21.3' versus 'HISTOLOGICAL_TYPE'

P value = 2e-05 (Fisher's exact test), Q value = 0.00011

Table S14. Gene #4: 'amp_1q21.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 4(1Q21.3) MUTATED	154	10	72
AMP PEAK 4(1Q21.3) WILD-TYPE	241	11	40

Figure S14. Get High-res Image Gene #4: 'amp_1q21.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_1q21.3' versus 'RACE'

P value = 0.00663 (Fisher's exact test), Q value = 0.017

Table S15. Gene #4: 'amp_1q21.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 4(1Q21.3) MUTATED	2	5	59	2	156
AMP PEAK 4(1Q21.3) WILD-TYPE	2	15	42	7	210

Figure S15. Get High-res Image Gene #4: 'amp_1q21.3' versus Clinical Feature #6: 'RACE'

'amp_1q22' versus 'Time to Death'

P value = 0.000798 (logrank test), Q value = 0.0029

Table S16. Gene #5: 'amp_1q22' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 5(1Q22) MUTATED	249	44	0.1 - 149.6 (20.9)
AMP PEAK 5(1Q22) WILD-TYPE	277	25	0.2 - 191.8 (24.3)

Figure S16. Get High-res Image Gene #5: 'amp_1q22' versus Clinical Feature #1: 'Time to Death'

'amp_1q22' versus 'YEARS_TO_BIRTH'

P value = 4.65e-08 (Wilcoxon-test), Q value = 2.2e-06

Table S17. Gene #5: 'amp_1q22' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 5(1Q22) MUTATED	249	66.9 (10.4)
AMP PEAK 5(1Q22) WILD-TYPE	277	61.4 (11.3)

Figure S17. Get High-res Image Gene #5: 'amp_1q22' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1q22' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S18. Gene #5: 'amp_1q22' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 5(1Q22) MUTATED	160	10	79
AMP PEAK 5(1Q22) WILD-TYPE	235	11	33

Figure S18. Get High-res Image Gene #5: 'amp_1q22' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_1q22' versus 'RACE'

P value = 0.0165 (Fisher's exact test), Q value = 0.037

Table S19. Gene #5: 'amp_1q22' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 5(1Q22) MUTATED	2	5	59	2	170
AMP PEAK 5(1Q22) WILD-TYPE	2	15	42	7	196

Figure S19. Get High-res Image Gene #5: 'amp_1q22' versus Clinical Feature #6: 'RACE'

'amp_1q44' versus 'Time to Death'

P value = 0.0718 (logrank test), Q value = 0.13

Table S20. Gene #6: 'amp_1q44' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 6(1Q44) MUTATED	212	34	0.1 - 149.6 (21.1)
AMP PEAK 6(1Q44) WILD-TYPE	314	35	0.2 - 191.8 (23.9)

Figure S20. Get High-res Image Gene #6: 'amp_1q44' versus Clinical Feature #1: 'Time to Death'

'amp_1q44' versus 'YEARS_TO_BIRTH'

P value = 0.00104 (Wilcoxon-test), Q value = 0.0037

Table S21. Gene #6: 'amp_1q44' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 6(1Q44) MUTATED	213	66.0 (10.4)
AMP PEAK 6(1Q44) WILD-TYPE	313	62.6 (11.6)

Figure S21. Get High-res Image Gene #6: 'amp_1q44' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_2p24.3' versus 'Time to Death'

P value = 6.26e-05 (logrank test), Q value = 0.00032

Table S22. Gene #7: 'amp_2p24.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 7(2P24.3) MUTATED	117	28	0.1 - 149.6 (22.3)
AMP PEAK 7(2P24.3) WILD-TYPE	409	41	0.1 - 191.8 (23.4)

Figure S22. Get High-res Image Gene #7: 'amp_2p24.3' versus Clinical Feature #1: 'Time to Death'

'amp_2p24.3' versus 'YEARS_TO_BIRTH'

P value = 0.0135 (Wilcoxon-test), Q value = 0.032

Table S23. Gene #7: 'amp_2p24.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 7(2P24.3) MUTATED	117	66.2 (10.4)
AMP PEAK 7(2P24.3) WILD-TYPE	409	63.4 (11.4)

Figure S23. Get High-res Image Gene #7: 'amp_2p24.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_2p24.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S24. Gene #7: 'amp_2p24.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 7(2P24.3) MUTATED	54	7	57
AMP PEAK 7(2P24.3) WILD-TYPE	341	14	55

Figure S24. Get High-res Image Gene #7: 'amp_2p24.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_2p24.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0251 (Fisher's exact test), Q value = 0.054

Table S25. Gene #7: 'amp_2p24.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 7(2P24.3) MUTATED	22	96
AMP PEAK 7(2P24.3) WILD-TYPE	119	291

Figure S25. Get High-res Image Gene #7: 'amp_2p24.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_2q13' versus 'Time to Death'

P value = 4.22e-05 (logrank test), Q value = 0.00023

Table S26. Gene #8: 'amp_2q13' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 8(2Q13) MUTATED	115	28	0.3 - 149.6 (20.9)
AMP PEAK 8(2Q13) WILD-TYPE	411	41	0.1 - 191.8 (23.9)

Figure S26. Get High-res Image Gene #8: 'amp_2q13' versus Clinical Feature #1: 'Time to Death'

'amp_2q13' versus 'YEARS_TO_BIRTH'

P value = 0.00032 (Wilcoxon-test), Q value = 0.0013

Table S27. Gene #8: 'amp_2q13' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 8(2Q13) MUTATED	115	67.1 (9.1)
AMP PEAK 8(2Q13) WILD-TYPE	411	63.2 (11.6)

Figure S27. Get High-res Image Gene #8: 'amp_2q13' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_2q13' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S28. Gene #8: 'amp_2q13' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 8(2Q13) MUTATED	44	5	67
AMP PEAK 8(2Q13) WILD-TYPE	351	16	45

Figure S28. Get High-res Image Gene #8: 'amp_2q13' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_3p25.1' versus 'Time to Death'

P value = 0.031 (logrank test), Q value = 0.064

Table S29. Gene #9: 'amp_3p25.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 9(3P25.1) MUTATED	80	18	0.1 - 191.8 (27.1)
AMP PEAK 9(3P25.1) WILD-TYPE	446	51	0.1 - 185.8 (23.2)

Figure S29. Get High-res Image Gene #9: 'amp_3p25.1' versus Clinical Feature #1: 'Time to Death'

'amp_3p25.1' versus 'YEARS_TO_BIRTH'

P value = 0.000276 (Wilcoxon-test), Q value = 0.0011

Table S30. Gene #9: 'amp_3p25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 9(3P25.1) MUTATED	80	68.5 (10.6)
AMP PEAK 9(3P25.1) WILD-TYPE	446	63.2 (11.2)

Figure S30. Get High-res Image Gene #9: 'amp_3p25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_3p25.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S31. Gene #9: 'amp_3p25.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 9(3P25.1) MUTATED	36	1	43
AMP PEAK 9(3P25.1) WILD-TYPE	359	20	69

Figure S31. Get High-res Image Gene #9: 'amp_3p25.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_3p25.1' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0992 (Fisher's exact test), Q value = 0.17

Table S32. Gene #9: 'amp_3p25.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 9(3P25.1) MUTATED	15	65
AMP PEAK 9(3P25.1) WILD-TYPE	126	322

Figure S32. Get High-res Image Gene #9: 'amp_3p25.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_3p25.1' versus 'RACE'

P value = 0.00328 (Fisher's exact test), Q value = 0.0097

Table S33. Gene #9: 'amp_3p25.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 9(3P25.1) MUTATED	0	0	23	4	47
AMP PEAK 9(3P25.1) WILD-TYPE	4	20	78	5	319

Figure S33. Get High-res Image Gene #9: 'amp_3p25.1' versus Clinical Feature #6: 'RACE'

'amp_3p14.1' versus 'Time to Death'

P value = 0.00125 (logrank test), Q value = 0.0042

Table S34. Gene #10: 'amp_3p14.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 10(3P14.1) MUTATED	63	17	0.1 - 191.8 (27.2)
AMP PEAK 10(3P14.1) WILD-TYPE	463	52	0.1 - 185.8 (23.3)

Figure S34. Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #1: 'Time to Death'

'amp_3p14.1' versus 'YEARS_TO_BIRTH'

P value = 0.00377 (Wilcoxon-test), Q value = 0.011

Table S35. Gene #10: 'amp_3p14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 10(3P14.1) MUTATED	63	68.1 (10.3)
AMP PEAK 10(3P14.1) WILD-TYPE	463	63.5 (11.2)

Figure S35. Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_3p14.1' versus 'HISTOLOGICAL_TYPE'

P value = 8e-05 (Fisher's exact test), Q value = 4e-04

Table S36. Gene #10: 'amp_3p14.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 10(3P14.1) MUTATED	33	3	27
AMP PEAK 10(3P14.1) WILD-TYPE	362	18	85

Figure S36. Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_3p14.1' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0476 (Fisher's exact test), Q value = 0.093

Table S37. Gene #10: 'amp_3p14.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 10(3P14.1) MUTATED	10	53
AMP PEAK 10(3P14.1) WILD-TYPE	131	334

Figure S37. Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_3p14.1' versus 'RACE'

P value = 0.0109 (Fisher's exact test), Q value = 0.026

Table S38. Gene #10: 'amp_3p14.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 10(3P14.1) MUTATED	1	0	15	4	39
AMP PEAK 10(3P14.1) WILD-TYPE	3	20	86	5	327

Figure S38. Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #6: 'RACE'

'amp_3p14.1' versus 'ETHNICITY'

P value = 0.0802 (Fisher's exact test), Q value = 0.15

Table S39. Gene #10: 'amp_3p14.1' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	14	367
AMP PEAK 10(3P14.1) MUTATED	4	43
AMP PEAK 10(3P14.1) WILD-TYPE	10	324

Figure S39. Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #7: 'ETHNICITY'

'amp_3q26.2' versus 'Time to Death'

P value = 0.000911 (logrank test), Q value = 0.0033

Table S40. Gene #11: 'amp_3q26.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 11(3Q26.2) MUTATED	171	34	0.1 - 191.8 (22.1)
AMP PEAK 11(3Q26.2) WILD-TYPE	355	35	0.2 - 185.8 (23.5)

Figure S40. Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #1: 'Time to Death'

'amp_3q26.2' versus 'YEARS_TO_BIRTH'

P value = 2.54e-11 (Wilcoxon-test), Q value = 1.8e-08

Table S41. Gene #11: 'amp_3q26.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 11(3Q26.2) MUTATED	170	68.4 (9.3)
AMP PEAK 11(3Q26.2) WILD-TYPE	356	61.9 (11.4)

Figure S41. Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_3q26.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S42. Gene #11: 'amp_3q26.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 11(3Q26.2) MUTATED	73	8	90
AMP PEAK 11(3Q26.2) WILD-TYPE	322	13	22

Figure S42. Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_3q26.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0273 (Fisher's exact test), Q value = 0.058

Table S43. Gene #11: 'amp_3q26.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 11(3Q26.2) MUTATED	35	136
AMP PEAK 11(3Q26.2) WILD-TYPE	106	251

Figure S43. Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_3q26.2' versus 'RACE'

P value = 2e-05 (Fisher's exact test), Q value = 0.00011

Table S44. Gene #11: 'amp_3q26.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 11(3Q26.2) MUTATED	0	3	52	4	100
AMP PEAK 11(3Q26.2) WILD-TYPE	4	17	49	5	266

Figure S44. Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #6: 'RACE'

'amp_3q26.2' versus 'Time to Death'

P value = 0.00286 (logrank test), Q value = 0.0086

Table S45. Gene #12: 'amp_3q26.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 12(3Q26.2) MUTATED	159	31	0.1 - 191.8 (22.1)
AMP PEAK 12(3Q26.2) WILD-TYPE	367	38	0.2 - 185.8 (23.5)

Figure S45. Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #1: 'Time to Death'

'amp_3q26.2' versus 'YEARS_TO_BIRTH'

P value = 3.3e-09 (Wilcoxon-test), Q value = 4.6e-07

Table S46. Gene #12: 'amp_3q26.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 12(3Q26.2) MUTATED	158	68.2 (9.4)
AMP PEAK 12(3Q26.2) WILD-TYPE	368	62.2 (11.5)

Figure S46. Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_3q26.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S47. Gene #12: 'amp_3q26.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 12(3Q26.2) MUTATED	65	7	87
AMP PEAK 12(3Q26.2) WILD-TYPE	330	14	25

Figure S47. Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_3q26.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0533 (Fisher's exact test), Q value = 0.1

Table S48. Gene #12: 'amp_3q26.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 12(3Q26.2) MUTATED	33	126
AMP PEAK 12(3Q26.2) WILD-TYPE	108	261

Figure S48. Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_3q26.2' versus 'RACE'

P value = 0.00015 (Fisher's exact test), Q value = 0.00069

Table S49. Gene #12: 'amp_3q26.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 12(3Q26.2) MUTATED	0	3	48	4	93
AMP PEAK 12(3Q26.2) WILD-TYPE	4	17	53	5	273

Figure S49. Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #6: 'RACE'

'amp_4p16.3' versus 'YEARS_TO_BIRTH'

P value = 2.74e-05 (Wilcoxon-test), Q value = 0.00015

Table S50. Gene #13: 'amp_4p16.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 13(4P16.3) MUTATED	52	69.7 (9.0)
AMP PEAK 13(4P16.3) WILD-TYPE	474	63.4 (11.3)

Figure S50. Get High-res Image Gene #13: 'amp_4p16.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_4p16.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S51. Gene #13: 'amp_4p16.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 13(4P16.3) MUTATED	15	1	36
AMP PEAK 13(4P16.3) WILD-TYPE	380	20	76

Figure S51. Get High-res Image Gene #13: 'amp_4p16.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_5p15.33' versus 'Time to Death'

P value = 0.000241 (logrank test), Q value = 0.001

Table S52. Gene #14: 'amp_5p15.33' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 14(5P15.33) MUTATED	87	21	0.2 - 125.4 (20.8)
AMP PEAK 14(5P15.33) WILD-TYPE	439	48	0.1 - 191.8 (23.5)

Figure S52. Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #1: 'Time to Death'

'amp_5p15.33' versus 'YEARS_TO_BIRTH'

P value = 0.000107 (Wilcoxon-test), Q value = 5e-04

Table S53. Gene #14: 'amp_5p15.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 14(5P15.33) MUTATED	88	67.7 (10.0)
AMP PEAK 14(5P15.33) WILD-TYPE	438	63.3 (11.3)

Figure S53. Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_5p15.33' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S54. Gene #14: 'amp_5p15.33' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 14(5P15.33) MUTATED	30	3	55
AMP PEAK 14(5P15.33) WILD-TYPE	365	18	57

Figure S54. Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_5p15.33' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.113 (Fisher's exact test), Q value = 0.19

Table S55. Gene #14: 'amp_5p15.33' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 14(5P15.33) MUTATED	17	71
AMP PEAK 14(5P15.33) WILD-TYPE	124	316

Figure S55. Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_5p15.33' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.133 (Fisher's exact test), Q value = 0.22

Table S56. Gene #14: 'amp_5p15.33' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
AMP PEAK 14(5P15.33) MUTATED	57	3	6	8
AMP PEAK 14(5P15.33) WILD-TYPE	306	20	11	27

Figure S56. Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_5p15.33' versus 'RACE'

P value = 0.00247 (Fisher's exact test), Q value = 0.0076

Table S57. Gene #14: 'amp_5p15.33' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 14(5P15.33) MUTATED	1	2	30	2	49
AMP PEAK 14(5P15.33) WILD-TYPE	3	18	71	7	317

Figure S57. Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #6: 'RACE'

'amp_5q35.3' versus 'Time to Death'

P value = 0.00614 (logrank test), Q value = 0.016

Table S58. Gene #15: 'amp_5q35.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 15(5Q35.3) MUTATED	52	11	0.4 - 96.7 (16.2)
AMP PEAK 15(5Q35.3) WILD-TYPE	474	58	0.1 - 191.8 (23.8)

Figure S58. Get High-res Image Gene #15: 'amp_5q35.3' versus Clinical Feature #1: 'Time to Death'

'amp_5q35.3' versus 'YEARS_TO_BIRTH'

P value = 0.000282 (Wilcoxon-test), Q value = 0.0011

Table S59. Gene #15: 'amp_5q35.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 15(5Q35.3) MUTATED	53	69.3 (10.3)
AMP PEAK 15(5Q35.3) WILD-TYPE	473	63.4 (11.2)

Figure S59. Get High-res Image Gene #15: 'amp_5q35.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_5q35.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S60. Gene #15: 'amp_5q35.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 15(5Q35.3) MUTATED	20	2	31
AMP PEAK 15(5Q35.3) WILD-TYPE	375	19	81

Figure S60. Get High-res Image Gene #15: 'amp_5q35.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_5q35.3' versus 'RACE'

P value = 0.0197 (Fisher's exact test), Q value = 0.044

Table S61. Gene #15: 'amp_5q35.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 15(5Q35.3) MUTATED	0	1	20	0	30
AMP PEAK 15(5Q35.3) WILD-TYPE	4	19	81	9	336

Figure S61. Get High-res Image Gene #15: 'amp_5q35.3' versus Clinical Feature #6: 'RACE'

'amp_6p24.2' versus 'Time to Death'

P value = 0.0559 (logrank test), Q value = 0.11

Table S62. Gene #16: 'amp_6p24.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 16(6P24.2) MUTATED	114	22	0.1 - 125.4 (27.3)
AMP PEAK 16(6P24.2) WILD-TYPE	412	47	0.2 - 191.8 (22.7)

Figure S62. Get High-res Image Gene #16: 'amp_6p24.2' versus Clinical Feature #1: 'Time to Death'

'amp_6p24.2' versus 'YEARS_TO_BIRTH'

P value = 2.5e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S63. Gene #16: 'amp_6p24.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 16(6P24.2) MUTATED	114	68.1 (9.9)
AMP PEAK 16(6P24.2) WILD-TYPE	412	62.9 (11.3)

Figure S63. Get High-res Image Gene #16: 'amp_6p24.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_6p24.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S64. Gene #16: 'amp_6p24.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 16(6P24.2) MUTATED	45	5	64
AMP PEAK 16(6P24.2) WILD-TYPE	350	16	48

Figure S64. Get High-res Image Gene #16: 'amp_6p24.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_6p24.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0937 (Fisher's exact test), Q value = 0.16

Table S65. Gene #16: 'amp_6p24.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 16(6P24.2) MUTATED	23	91
AMP PEAK 16(6P24.2) WILD-TYPE	118	296

Figure S65. Get High-res Image Gene #16: 'amp_6p24.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_6p22.3' versus 'YEARS_TO_BIRTH'

P value = 0.000195 (Wilcoxon-test), Q value = 0.00086

Table S66. Gene #17: 'amp_6p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 17(6P22.3) MUTATED	104	67.4 (9.9)
AMP PEAK 17(6P22.3) WILD-TYPE	422	63.2 (11.4)

Figure S66. Get High-res Image Gene #17: 'amp_6p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_6p22.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S67. Gene #17: 'amp_6p22.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 17(6P22.3) MUTATED	40	4	60
AMP PEAK 17(6P22.3) WILD-TYPE	355	17	52

Figure S67. Get High-res Image Gene #17: 'amp_6p22.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_6p22.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.108 (Fisher's exact test), Q value = 0.18

Table S68. Gene #17: 'amp_6p22.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 17(6P22.3) MUTATED	21	83
AMP PEAK 17(6P22.3) WILD-TYPE	120	304

Figure S68. Get High-res Image Gene #17: 'amp_6p22.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_6p22.3' versus 'RACE'

P value = 0.00738 (Fisher's exact test), Q value = 0.019

Table S69. Gene #17: 'amp_6p22.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 17(6P22.3) MUTATED	0	2	33	2	62
AMP PEAK 17(6P22.3) WILD-TYPE	4	18	68	7	304

Figure S69. Get High-res Image Gene #17: 'amp_6p22.3' versus Clinical Feature #6: 'RACE'

'amp_6q25.1' versus 'Time to Death'

P value = 0.0921 (logrank test), Q value = 0.16

Table S70. Gene #18: 'amp_6q25.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 18(6Q25.1) MUTATED	84	15	0.1 - 97.7 (22.8)
AMP PEAK 18(6Q25.1) WILD-TYPE	442	54	0.2 - 191.8 (23.4)

Figure S70. Get High-res Image Gene #18: 'amp_6q25.1' versus Clinical Feature #1: 'Time to Death'

'amp_6q25.1' versus 'YEARS_TO_BIRTH'

P value = 0.00172 (Wilcoxon-test), Q value = 0.0055

Table S71. Gene #18: 'amp_6q25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 18(6Q25.1) MUTATED	84	67.0 (10.5)
AMP PEAK 18(6Q25.1) WILD-TYPE	442	63.4 (11.3)

Figure S71. Get High-res Image Gene #18: 'amp_6q25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_6q25.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S72. Gene #18: 'amp_6q25.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 18(6Q25.1) MUTATED	44	2	38
AMP PEAK 18(6Q25.1) WILD-TYPE	351	19	74

Figure S72. Get High-res Image Gene #18: 'amp_6q25.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_6q25.1' versus 'RACE'

P value = 0.00526 (Fisher's exact test), Q value = 0.014

Table S73. Gene #18: 'amp_6q25.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 18(6Q25.1) MUTATED	0	1	28	2	48
AMP PEAK 18(6Q25.1) WILD-TYPE	4	19	73	7	318

Figure S73. Get High-res Image Gene #18: 'amp_6q25.1' versus Clinical Feature #6: 'RACE'

'amp_7q31.2' versus 'Time to Death'

P value = 8.52e-07 (logrank test), Q value = 2.7e-05

Table S74. Gene #19: 'amp_7q31.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 19(7Q31.2) MUTATED	89	23	0.2 - 125.4 (16.9)
AMP PEAK 19(7Q31.2) WILD-TYPE	437	46	0.1 - 191.8 (24.4)

Figure S74. Get High-res Image Gene #19: 'amp_7q31.2' versus Clinical Feature #1: 'Time to Death'

'amp_7q31.2' versus 'YEARS_TO_BIRTH'

P value = 0.0795 (Wilcoxon-test), Q value = 0.14

Table S75. Gene #19: 'amp_7q31.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 19(7Q31.2) MUTATED	89	65.9 (11.9)
AMP PEAK 19(7Q31.2) WILD-TYPE	437	63.6 (11.1)

Figure S75. Get High-res Image Gene #19: 'amp_7q31.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_7q31.2' versus 'HISTOLOGICAL_TYPE'

P value = 7e-05 (Fisher's exact test), Q value = 0.00036

Table S76. Gene #19: 'amp_7q31.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 19(7Q31.2) MUTATED	51	5	34
AMP PEAK 19(7Q31.2) WILD-TYPE	344	16	78

Figure S76. Get High-res Image Gene #19: 'amp_7q31.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_7q31.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0184 (Fisher's exact test), Q value = 0.041

Table S77. Gene #19: 'amp_7q31.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 19(7Q31.2) MUTATED	15	75
AMP PEAK 19(7Q31.2) WILD-TYPE	126	312

Figure S77. Get High-res Image Gene #19: 'amp_7q31.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_8p11.22' versus 'Time to Death'

P value = 0.00209 (logrank test), Q value = 0.0065

Table S78. Gene #20: 'amp_8p11.22' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 20(8P11.22) MUTATED	125	25	0.1 - 118.0 (19.6)
AMP PEAK 20(8P11.22) WILD-TYPE	401	44	0.1 - 191.8 (24.0)

Figure S78. Get High-res Image Gene #20: 'amp_8p11.22' versus Clinical Feature #1: 'Time to Death'

'amp_8p11.21' versus 'Time to Death'

P value = 1.13e-05 (logrank test), Q value = 6.6e-05

Table S79. Gene #21: 'amp_8p11.21' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 21(8P11.21) MUTATED	161	35	0.1 - 125.4 (19.4)
AMP PEAK 21(8P11.21) WILD-TYPE	365	34	0.2 - 191.8 (25.0)

Figure S79. Get High-res Image Gene #21: 'amp_8p11.21' versus Clinical Feature #1: 'Time to Death'

'amp_8p11.21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S80. Gene #21: 'amp_8p11.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 21(8P11.21) MUTATED	94	7	60
AMP PEAK 21(8P11.21) WILD-TYPE	301	14	52

Figure S80. Get High-res Image Gene #21: 'amp_8p11.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_8p11.21' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.019 (Fisher's exact test), Q value = 0.042

Table S81. Gene #21: 'amp_8p11.21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 21(8P11.21) MUTATED	32	129
AMP PEAK 21(8P11.21) WILD-TYPE	109	258

Figure S81. Get High-res Image Gene #21: 'amp_8p11.21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_8p11.21' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.00642 (Fisher's exact test), Q value = 0.017

Table S82. Gene #21: 'amp_8p11.21' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
AMP PEAK 21(8P11.21) MUTATED	106	4	11	14
AMP PEAK 21(8P11.21) WILD-TYPE	257	19	6	21

Figure S82. Get High-res Image Gene #21: 'amp_8p11.21' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_8q24.21' versus 'Time to Death'

P value = 0.000217 (logrank test), Q value = 0.00092

Table S83. Gene #22: 'amp_8q24.21' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 22(8Q24.21) MUTATED	204	40	0.1 - 191.8 (20.7)
AMP PEAK 22(8Q24.21) WILD-TYPE	322	29	0.2 - 185.8 (24.8)

Figure S83. Get High-res Image Gene #22: 'amp_8q24.21' versus Clinical Feature #1: 'Time to Death'

'amp_8q24.21' versus 'YEARS_TO_BIRTH'

P value = 0.0412 (Wilcoxon-test), Q value = 0.083

Table S84. Gene #22: 'amp_8q24.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 22(8Q24.21) MUTATED	204	64.8 (11.7)
AMP PEAK 22(8Q24.21) WILD-TYPE	322	63.5 (10.9)

Figure S84. Get High-res Image Gene #22: 'amp_8q24.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_8q24.21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S85. Gene #22: 'amp_8q24.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 22(8Q24.21) MUTATED	116	10	80
AMP PEAK 22(8Q24.21) WILD-TYPE	279	11	32

Figure S85. Get High-res Image Gene #22: 'amp_8q24.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_8q24.21' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00478 (Fisher's exact test), Q value = 0.013

Table S86. Gene #22: 'amp_8q24.21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 22(8Q24.21) MUTATED	41	165
AMP PEAK 22(8Q24.21) WILD-TYPE	100	222

Figure S86. Get High-res Image Gene #22: 'amp_8q24.21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_8q24.21' versus 'Time to Death'

P value = 0.000397 (logrank test), Q value = 0.0015

Table S87. Gene #23: 'amp_8q24.21' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 23(8Q24.21) MUTATED	210	40	0.1 - 191.8 (20.7)
AMP PEAK 23(8Q24.21) WILD-TYPE	316	29	0.2 - 185.8 (25.0)

Figure S87. Get High-res Image Gene #23: 'amp_8q24.21' versus Clinical Feature #1: 'Time to Death'

'amp_8q24.21' versus 'YEARS_TO_BIRTH'

P value = 0.0149 (Wilcoxon-test), Q value = 0.034

Table S88. Gene #23: 'amp_8q24.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 23(8Q24.21) MUTATED	210	65.1 (11.6)
AMP PEAK 23(8Q24.21) WILD-TYPE	316	63.3 (10.9)

Figure S88. Get High-res Image Gene #23: 'amp_8q24.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_8q24.21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S89. Gene #23: 'amp_8q24.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 23(8Q24.21) MUTATED	119	9	84
AMP PEAK 23(8Q24.21) WILD-TYPE	276	12	28

Figure S89. Get High-res Image Gene #23: 'amp_8q24.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_8q24.21' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00359 (Fisher's exact test), Q value = 0.01

Table S90. Gene #23: 'amp_8q24.21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 23(8Q24.21) MUTATED	42	170
AMP PEAK 23(8Q24.21) WILD-TYPE	99	217

Figure S90. Get High-res Image Gene #23: 'amp_8q24.21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_8q24.21' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0114 (Fisher's exact test), Q value = 0.028

Table S91. Gene #23: 'amp_8q24.21' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
AMP PEAK 23(8Q24.21) MUTATED	143	6	13	14
AMP PEAK 23(8Q24.21) WILD-TYPE	220	17	4	21

Figure S91. Get High-res Image Gene #23: 'amp_8q24.21' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_9p24.2' versus 'Time to Death'

P value = 0.0302 (logrank test), Q value = 0.062

Table S92. Gene #24: 'amp_9p24.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 24(9P24.2) MUTATED	63	14	0.1 - 125.4 (24.0)
AMP PEAK 24(9P24.2) WILD-TYPE	463	55	0.1 - 191.8 (23.3)

Figure S92. Get High-res Image Gene #24: 'amp_9p24.2' versus Clinical Feature #1: 'Time to Death'

'amp_9p24.2' versus 'YEARS_TO_BIRTH'

P value = 0.00194 (Wilcoxon-test), Q value = 0.0061

Table S93. Gene #24: 'amp_9p24.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 24(9P24.2) MUTATED	64	67.4 (9.2)
AMP PEAK 24(9P24.2) WILD-TYPE	462	63.5 (11.4)

Figure S93. Get High-res Image Gene #24: 'amp_9p24.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_9p24.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S94. Gene #24: 'amp_9p24.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 24(9P24.2) MUTATED	25	3	36
AMP PEAK 24(9P24.2) WILD-TYPE	370	18	76

Figure S94. Get High-res Image Gene #24: 'amp_9p24.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_9p24.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.135 (Fisher's exact test), Q value = 0.22

Table S95. Gene #24: 'amp_9p24.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
AMP PEAK 24(9P24.2) MUTATED	39	3	3	8
AMP PEAK 24(9P24.2) WILD-TYPE	324	20	14	27

Figure S95. Get High-res Image Gene #24: 'amp_9p24.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_9p24.2' versus 'ETHNICITY'

P value = 0.0214 (Fisher's exact test), Q value = 0.047

Table S96. Gene #24: 'amp_9p24.2' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	14	367
AMP PEAK 24(9P24.2) MUTATED	5	43
AMP PEAK 24(9P24.2) WILD-TYPE	9	324

Figure S96. Get High-res Image Gene #24: 'amp_9p24.2' versus Clinical Feature #7: 'ETHNICITY'

'amp_9q34.3' versus 'Time to Death'

P value = 0.0429 (logrank test), Q value = 0.086

Table S97. Gene #25: 'amp_9q34.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 25(9Q34.3) MUTATED	38	8	0.1 - 71.2 (20.1)
AMP PEAK 25(9Q34.3) WILD-TYPE	488	61	0.1 - 191.8 (23.4)

Figure S97. Get High-res Image Gene #25: 'amp_9q34.3' versus Clinical Feature #1: 'Time to Death'

'amp_9q34.3' versus 'YEARS_TO_BIRTH'

P value = 0.00159 (Wilcoxon-test), Q value = 0.0052

Table S98. Gene #25: 'amp_9q34.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 25(9Q34.3) MUTATED	38	69.3 (8.1)
AMP PEAK 25(9Q34.3) WILD-TYPE	488	63.6 (11.3)

Figure S98. Get High-res Image Gene #25: 'amp_9q34.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_9q34.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S99. Gene #25: 'amp_9q34.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 25(9Q34.3) MUTATED	13	4	21
AMP PEAK 25(9Q34.3) WILD-TYPE	382	17	91

Figure S99. Get High-res Image Gene #25: 'amp_9q34.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_9q34.3' versus 'RACE'

P value = 0.00983 (Fisher's exact test), Q value = 0.024

Table S100. Gene #25: 'amp_9q34.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 25(9Q34.3) MUTATED	0	1	17	0	20
AMP PEAK 25(9Q34.3) WILD-TYPE	4	19	84	9	346

Figure S100. Get High-res Image Gene #25: 'amp_9q34.3' versus Clinical Feature #6: 'RACE'

'amp_10q22.2' versus 'Time to Death'

P value = 0.0931 (logrank test), Q value = 0.16

Table S101. Gene #26: 'amp_10q22.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 26(10Q22.2) MUTATED	142	24	0.6 - 185.8 (22.8)
AMP PEAK 26(10Q22.2) WILD-TYPE	384	45	0.1 - 191.8 (23.4)

Figure S101. Get High-res Image Gene #26: 'amp_10q22.2' versus Clinical Feature #1: 'Time to Death'

'amp_10q22.2' versus 'HISTOLOGICAL_TYPE'

P value = 0.00337 (Fisher's exact test), Q value = 0.0099

Table S102. Gene #26: 'amp_10q22.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 26(10Q22.2) MUTATED	96	3	44
AMP PEAK 26(10Q22.2) WILD-TYPE	299	18	68

Figure S102. Get High-res Image Gene #26: 'amp_10q22.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_11p11.2' versus 'Time to Death'

P value = 0.00175 (logrank test), Q value = 0.0056

Table S103. Gene #27: 'amp_11p11.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 27(11P11.2) MUTATED	50	13	1.4 - 110.1 (20.1)
AMP PEAK 27(11P11.2) WILD-TYPE	476	56	0.1 - 191.8 (23.6)

Figure S103. Get High-res Image Gene #27: 'amp_11p11.2' versus Clinical Feature #1: 'Time to Death'

'amp_11p11.2' versus 'YEARS_TO_BIRTH'

P value = 0.000211 (Wilcoxon-test), Q value = 9e-04

Table S104. Gene #27: 'amp_11p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 27(11P11.2) MUTATED	50	69.7 (9.5)
AMP PEAK 27(11P11.2) WILD-TYPE	476	63.4 (11.2)

Figure S104. Get High-res Image Gene #27: 'amp_11p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_11p11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S105. Gene #27: 'amp_11p11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 27(11P11.2) MUTATED	16	4	30
AMP PEAK 27(11P11.2) WILD-TYPE	379	17	82

Figure S105. Get High-res Image Gene #27: 'amp_11p11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_11q13.2' versus 'Time to Death'

P value = 0.00465 (logrank test), Q value = 0.013

Table S106. Gene #28: 'amp_11q13.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 28(11Q13.2) MUTATED	70	16	0.1 - 80.4 (24.0)
AMP PEAK 28(11Q13.2) WILD-TYPE	456	53	0.1 - 191.8 (23.3)

Figure S106. Get High-res Image Gene #28: 'amp_11q13.2' versus Clinical Feature #1: 'Time to Death'

'amp_11q13.2' versus 'YEARS_TO_BIRTH'

P value = 0.000622 (Wilcoxon-test), Q value = 0.0023

Table S107. Gene #28: 'amp_11q13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 28(11Q13.2) MUTATED	70	68.1 (9.9)
AMP PEAK 28(11Q13.2) WILD-TYPE	456	63.4 (11.3)

Figure S107. Get High-res Image Gene #28: 'amp_11q13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_11q13.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S108. Gene #28: 'amp_11q13.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 28(11Q13.2) MUTATED	33	3	34
AMP PEAK 28(11Q13.2) WILD-TYPE	362	18	78

Figure S108. Get High-res Image Gene #28: 'amp_11q13.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_11q14.1' versus 'Time to Death'

P value = 5.34e-07 (logrank test), Q value = 2e-05

Table S109. Gene #29: 'amp_11q14.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 29(11Q14.1) MUTATED	56	18	0.4 - 102.3 (20.4)
AMP PEAK 29(11Q14.1) WILD-TYPE	470	51	0.1 - 191.8 (23.6)

Figure S109. Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #1: 'Time to Death'

'amp_11q14.1' versus 'YEARS_TO_BIRTH'

P value = 0.0108 (Wilcoxon-test), Q value = 0.026

Table S110. Gene #29: 'amp_11q14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 29(11Q14.1) MUTATED	56	67.7 (10.7)
AMP PEAK 29(11Q14.1) WILD-TYPE	470	63.6 (11.2)

Figure S110. Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_11q14.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S111. Gene #29: 'amp_11q14.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 29(11Q14.1) MUTATED	21	1	34
AMP PEAK 29(11Q14.1) WILD-TYPE	374	20	78

Figure S111. Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_11q14.1' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.15 (Fisher's exact test), Q value = 0.24

Table S112. Gene #29: 'amp_11q14.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 29(11Q14.1) MUTATED	10	46
AMP PEAK 29(11Q14.1) WILD-TYPE	131	341

Figure S112. Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_11q14.1' versus 'RACE'

P value = 0.101 (Fisher's exact test), Q value = 0.18

Table S113. Gene #29: 'amp_11q14.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 29(11Q14.1) MUTATED	1	0	16	1	35
AMP PEAK 29(11Q14.1) WILD-TYPE	3	20	85	8	331

Figure S113. Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #6: 'RACE'

'amp_12p12.1' versus 'YEARS_TO_BIRTH'

P value = 0.145 (Wilcoxon-test), Q value = 0.23

Table S114. Gene #30: 'amp_12p12.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 30(12P12.1) MUTATED	91	65.4 (11.5)
AMP PEAK 30(12P12.1) WILD-TYPE	435	63.7 (11.2)

Figure S114. Get High-res Image Gene #30: 'amp_12p12.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_12p12.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S115. Gene #30: 'amp_12p12.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 30(12P12.1) MUTATED	44	4	44
AMP PEAK 30(12P12.1) WILD-TYPE	351	17	68

Figure S115. Get High-res Image Gene #30: 'amp_12p12.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_12p12.1' versus 'RACE'

P value = 0.117 (Fisher's exact test), Q value = 0.2

Table S116. Gene #30: 'amp_12p12.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 30(12P12.1) MUTATED	0	6	24	2	56
AMP PEAK 30(12P12.1) WILD-TYPE	4	14	77	7	310

Figure S116. Get High-res Image Gene #30: 'amp_12p12.1' versus Clinical Feature #6: 'RACE'

'amp_12p12.1' versus 'ETHNICITY'

P value = 0.145 (Fisher's exact test), Q value = 0.23

Table S117. Gene #30: 'amp_12p12.1' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	14	367
AMP PEAK 30(12P12.1) MUTATED	0	68
AMP PEAK 30(12P12.1) WILD-TYPE	14	299

Figure S117. Get High-res Image Gene #30: 'amp_12p12.1' versus Clinical Feature #7: 'ETHNICITY'

'amp_12q13.11' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S118. Gene #31: 'amp_12q13.11' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 31(12Q13.11) MUTATED	39	4	41
AMP PEAK 31(12Q13.11) WILD-TYPE	356	17	71

Figure S118. Get High-res Image Gene #31: 'amp_12q13.11' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_12q13.11' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.106 (Fisher's exact test), Q value = 0.18

Table S119. Gene #31: 'amp_12q13.11' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 31(12Q13.11) MUTATED	16	68
AMP PEAK 31(12Q13.11) WILD-TYPE	125	319

Figure S119. Get High-res Image Gene #31: 'amp_12q13.11' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_12q13.11' versus 'RACE'

P value = 0.0178 (Fisher's exact test), Q value = 0.04

Table S120. Gene #31: 'amp_12q13.11' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 31(12Q13.11) MUTATED	1	6	23	3	49
AMP PEAK 31(12Q13.11) WILD-TYPE	3	14	78	6	317

Figure S120. Get High-res Image Gene #31: 'amp_12q13.11' versus Clinical Feature #6: 'RACE'

'amp_12q13.2' versus 'YEARS_TO_BIRTH'

P value = 0.113 (Wilcoxon-test), Q value = 0.19

Table S121. Gene #32: 'amp_12q13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 32(12Q13.2) MUTATED	97	65.4 (11.7)
AMP PEAK 32(12Q13.2) WILD-TYPE	429	63.7 (11.1)

Figure S121. Get High-res Image Gene #32: 'amp_12q13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_12q13.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S122. Gene #32: 'amp_12q13.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 32(12Q13.2) MUTATED	49	4	44
AMP PEAK 32(12Q13.2) WILD-TYPE	346	17	68

Figure S122. Get High-res Image Gene #32: 'amp_12q13.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_12q13.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0561 (Fisher's exact test), Q value = 0.11

Table S123. Gene #32: 'amp_12q13.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 32(12Q13.2) MUTATED	18	79
AMP PEAK 32(12Q13.2) WILD-TYPE	123	308

Figure S123. Get High-res Image Gene #32: 'amp_12q13.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_12q13.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.124 (Fisher's exact test), Q value = 0.21

Table S124. Gene #32: 'amp_12q13.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
AMP PEAK 32(12Q13.2) MUTATED	69	3	7	5
AMP PEAK 32(12Q13.2) WILD-TYPE	294	20	10	30

Figure S124. Get High-res Image Gene #32: 'amp_12q13.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_12q13.2' versus 'RACE'

P value = 0.124 (Fisher's exact test), Q value = 0.21

Table S125. Gene #32: 'amp_12q13.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 32(12Q13.2) MUTATED	1	6	25	2	59
AMP PEAK 32(12Q13.2) WILD-TYPE	3	14	76	7	307

Figure S125. Get High-res Image Gene #32: 'amp_12q13.2' versus Clinical Feature #6: 'RACE'

'amp_13q34' versus 'YEARS_TO_BIRTH'

P value = 8.49e-05 (Wilcoxon-test), Q value = 0.00042

Table S126. Gene #33: 'amp_13q34' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 33(13Q34) MUTATED	57	69.1 (7.4)
AMP PEAK 33(13Q34) WILD-TYPE	469	63.4 (11.4)

Figure S126. Get High-res Image Gene #33: 'amp_13q34' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_13q34' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S127. Gene #33: 'amp_13q34' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 33(13Q34) MUTATED	14	4	39
AMP PEAK 33(13Q34) WILD-TYPE	381	17	73

Figure S127. Get High-res Image Gene #33: 'amp_13q34' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_13q34' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0141 (Fisher's exact test), Q value = 0.033

Table S128. Gene #33: 'amp_13q34' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
AMP PEAK 33(13Q34) MUTATED	34	6	4	6
AMP PEAK 33(13Q34) WILD-TYPE	329	17	13	29

Figure S128. Get High-res Image Gene #33: 'amp_13q34' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_13q34' versus 'RACE'

P value = 0.0622 (Fisher's exact test), Q value = 0.12

Table S129. Gene #33: 'amp_13q34' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 33(13Q34) MUTATED	0	2	18	2	32
AMP PEAK 33(13Q34) WILD-TYPE	4	18	83	7	334

Figure S129. Get High-res Image Gene #33: 'amp_13q34' versus Clinical Feature #6: 'RACE'

'amp_14q24.3' versus 'Time to Death'

P value = 0.000162 (logrank test), Q value = 0.00074

Table S130. Gene #34: 'amp_14q24.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 34(14Q24.3) MUTATED	63	19	0.4 - 125.4 (23.7)
AMP PEAK 34(14Q24.3) WILD-TYPE	463	50	0.1 - 191.8 (23.3)

Figure S130. Get High-res Image Gene #34: 'amp_14q24.3' versus Clinical Feature #1: 'Time to Death'

'amp_14q24.3' versus 'YEARS_TO_BIRTH'

P value = 0.00117 (Wilcoxon-test), Q value = 0.004

Table S131. Gene #34: 'amp_14q24.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 34(14Q24.3) MUTATED	63	68.1 (9.0)
AMP PEAK 34(14Q24.3) WILD-TYPE	463	63.5 (11.4)

Figure S131. Get High-res Image Gene #34: 'amp_14q24.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_14q24.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S132. Gene #34: 'amp_14q24.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 34(14Q24.3) MUTATED	21	4	38
AMP PEAK 34(14Q24.3) WILD-TYPE	374	17	74

Figure S132. Get High-res Image Gene #34: 'amp_14q24.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_14q32.33' versus 'Time to Death'

P value = 0.00433 (logrank test), Q value = 0.012

Table S133. Gene #35: 'amp_14q32.33' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 35(14Q32.33) MUTATED	75	18	0.3 - 110.1 (23.9)
AMP PEAK 35(14Q32.33) WILD-TYPE	451	51	0.1 - 191.8 (23.3)

Figure S133. Get High-res Image Gene #35: 'amp_14q32.33' versus Clinical Feature #1: 'Time to Death'

'amp_14q32.33' versus 'YEARS_TO_BIRTH'

P value = 0.00112 (Wilcoxon-test), Q value = 0.0039

Table S134. Gene #35: 'amp_14q32.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 35(14Q32.33) MUTATED	76	67.6 (9.2)
AMP PEAK 35(14Q32.33) WILD-TYPE	450	63.4 (11.4)

Figure S134. Get High-res Image Gene #35: 'amp_14q32.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_14q32.33' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S135. Gene #35: 'amp_14q32.33' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 35(14Q32.33) MUTATED	30	5	41
AMP PEAK 35(14Q32.33) WILD-TYPE	365	16	71

Figure S135. Get High-res Image Gene #35: 'amp_14q32.33' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_14q32.33' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00784 (Fisher's exact test), Q value = 0.02

Table S136. Gene #35: 'amp_14q32.33' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 35(14Q32.33) MUTATED	11	65
AMP PEAK 35(14Q32.33) WILD-TYPE	130	322

Figure S136. Get High-res Image Gene #35: 'amp_14q32.33' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_14q32.33' versus 'RACE'

P value = 0.0198 (Fisher's exact test), Q value = 0.044

Table S137. Gene #35: 'amp_14q32.33' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 35(14Q32.33) MUTATED	0	0	23	2	46
AMP PEAK 35(14Q32.33) WILD-TYPE	4	20	78	7	320

Figure S137. Get High-res Image Gene #35: 'amp_14q32.33' versus Clinical Feature #6: 'RACE'

'amp_15q26.3' versus 'Time to Death'

P value = 0.00146 (logrank test), Q value = 0.0048

Table S138. Gene #36: 'amp_15q26.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 36(15Q26.3) MUTATED	37	12	1.7 - 110.1 (28.1)
AMP PEAK 36(15Q26.3) WILD-TYPE	489	57	0.1 - 191.8 (23.3)

Figure S138. Get High-res Image Gene #36: 'amp_15q26.3' versus Clinical Feature #1: 'Time to Death'

'amp_15q26.3' versus 'YEARS_TO_BIRTH'

P value = 0.00329 (Wilcoxon-test), Q value = 0.0097

Table S139. Gene #36: 'amp_15q26.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 36(15Q26.3) MUTATED	37	68.9 (11.2)
AMP PEAK 36(15Q26.3) WILD-TYPE	489	63.6 (11.1)

Figure S139. Get High-res Image Gene #36: 'amp_15q26.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_15q26.3' versus 'HISTOLOGICAL_TYPE'

P value = 9e-05 (Fisher's exact test), Q value = 0.00043

Table S140. Gene #36: 'amp_15q26.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 36(15Q26.3) MUTATED	17	1	19
AMP PEAK 36(15Q26.3) WILD-TYPE	378	20	93

Figure S140. Get High-res Image Gene #36: 'amp_15q26.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_15q26.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.081 (Fisher's exact test), Q value = 0.15

Table S141. Gene #36: 'amp_15q26.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 36(15Q26.3) MUTATED	5	32
AMP PEAK 36(15Q26.3) WILD-TYPE	136	355

Figure S141. Get High-res Image Gene #36: 'amp_15q26.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_15q26.3' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0122 (Fisher's exact test), Q value = 0.029

Table S142. Gene #36: 'amp_15q26.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
AMP PEAK 36(15Q26.3) MUTATED	20	3	4	4
AMP PEAK 36(15Q26.3) WILD-TYPE	343	20	13	31

Figure S142. Get High-res Image Gene #36: 'amp_15q26.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_16p11.2' versus 'Time to Death'

P value = 0.0156 (logrank test), Q value = 0.036

Table S143. Gene #37: 'amp_16p11.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 37(16P11.2) MUTATED	64	14	0.1 - 102.3 (22.0)
AMP PEAK 37(16P11.2) WILD-TYPE	462	55	0.1 - 191.8 (23.4)

Figure S143. Get High-res Image Gene #37: 'amp_16p11.2' versus Clinical Feature #1: 'Time to Death'

'amp_16p11.2' versus 'YEARS_TO_BIRTH'

P value = 0.000343 (Wilcoxon-test), Q value = 0.0013

Table S144. Gene #37: 'amp_16p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 37(16P11.2) MUTATED	64	68.3 (8.9)
AMP PEAK 37(16P11.2) WILD-TYPE	462	63.4 (11.4)

Figure S144. Get High-res Image Gene #37: 'amp_16p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_16p11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S145. Gene #37: 'amp_16p11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 37(16P11.2) MUTATED	22	2	40
AMP PEAK 37(16P11.2) WILD-TYPE	373	19	72

Figure S145. Get High-res Image Gene #37: 'amp_16p11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_16p11.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0732 (Fisher's exact test), Q value = 0.13

Table S146. Gene #37: 'amp_16p11.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
AMP PEAK 37(16P11.2) MUTATED	40	3	3	9
AMP PEAK 37(16P11.2) WILD-TYPE	323	20	14	26

Figure S146. Get High-res Image Gene #37: 'amp_16p11.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_16p11.2' versus 'RACE'

P value = 0.0954 (Fisher's exact test), Q value = 0.17

Table S147. Gene #37: 'amp_16p11.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 37(16P11.2) MUTATED	0	2	20	1	36
AMP PEAK 37(16P11.2) WILD-TYPE	4	18	81	8	330

Figure S147. Get High-res Image Gene #37: 'amp_16p11.2' versus Clinical Feature #6: 'RACE'

'amp_17q11.2' versus 'Time to Death'

P value = 0.00184 (logrank test), Q value = 0.0059

Table S148. Gene #38: 'amp_17q11.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 38(17Q11.2) MUTATED	71	16	0.1 - 110.1 (17.6)
AMP PEAK 38(17Q11.2) WILD-TYPE	455	53	0.1 - 191.8 (23.6)

Figure S148. Get High-res Image Gene #38: 'amp_17q11.2' versus Clinical Feature #1: 'Time to Death'

'amp_17q11.2' versus 'YEARS_TO_BIRTH'

P value = 0.00579 (Wilcoxon-test), Q value = 0.015

Table S149. Gene #38: 'amp_17q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 38(17Q11.2) MUTATED	70	67.5 (8.6)
AMP PEAK 38(17Q11.2) WILD-TYPE	456	63.5 (11.5)

Figure S149. Get High-res Image Gene #38: 'amp_17q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_17q11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S150. Gene #38: 'amp_17q11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 38(17Q11.2) MUTATED	19	6	46
AMP PEAK 38(17Q11.2) WILD-TYPE	376	15	66

Figure S150. Get High-res Image Gene #38: 'amp_17q11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_17q11.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.00113 (Fisher's exact test), Q value = 0.0039

Table S151. Gene #38: 'amp_17q11.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
AMP PEAK 38(17Q11.2) MUTATED	39	7	6	7
AMP PEAK 38(17Q11.2) WILD-TYPE	324	16	11	28

Figure S151. Get High-res Image Gene #38: 'amp_17q11.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_17q11.2' versus 'RACE'

P value = 0.00234 (Fisher's exact test), Q value = 0.0072

Table S152. Gene #38: 'amp_17q11.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 38(17Q11.2) MUTATED	1	1	25	2	38
AMP PEAK 38(17Q11.2) WILD-TYPE	3	19	76	7	328

Figure S152. Get High-res Image Gene #38: 'amp_17q11.2' versus Clinical Feature #6: 'RACE'

'amp_17q12' versus 'Time to Death'

P value = 0.000384 (logrank test), Q value = 0.0015

Table S153. Gene #39: 'amp_17q12' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 39(17Q12) MUTATED	74	18	0.1 - 110.1 (20.4)
AMP PEAK 39(17Q12) WILD-TYPE	452	51	0.1 - 191.8 (23.5)

Figure S153. Get High-res Image Gene #39: 'amp_17q12' versus Clinical Feature #1: 'Time to Death'

'amp_17q12' versus 'YEARS_TO_BIRTH'

P value = 0.0027 (Wilcoxon-test), Q value = 0.0081

Table S154. Gene #39: 'amp_17q12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 39(17Q12) MUTATED	73	68.0 (9.2)
AMP PEAK 39(17Q12) WILD-TYPE	453	63.4 (11.4)

Figure S154. Get High-res Image Gene #39: 'amp_17q12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_17q12' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S155. Gene #39: 'amp_17q12' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 39(17Q12) MUTATED	20	3	51
AMP PEAK 39(17Q12) WILD-TYPE	375	18	61

Figure S155. Get High-res Image Gene #39: 'amp_17q12' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_17q12' versus 'RACE'

P value = 0.0053 (Fisher's exact test), Q value = 0.014

Table S156. Gene #39: 'amp_17q12' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 39(17Q12) MUTATED	1	0	25	0	47
AMP PEAK 39(17Q12) WILD-TYPE	3	20	76	9	319

Figure S156. Get High-res Image Gene #39: 'amp_17q12' versus Clinical Feature #6: 'RACE'

'amp_17q25.1' versus 'Time to Death'

P value = 0.000212 (logrank test), Q value = 9e-04

Table S157. Gene #40: 'amp_17q25.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 40(17Q25.1) MUTATED	102	24	0.1 - 125.4 (21.4)
AMP PEAK 40(17Q25.1) WILD-TYPE	424	45	0.1 - 191.8 (23.8)

Figure S157. Get High-res Image Gene #40: 'amp_17q25.1' versus Clinical Feature #1: 'Time to Death'

'amp_17q25.1' versus 'YEARS_TO_BIRTH'

P value = 0.00112 (Wilcoxon-test), Q value = 0.0039

Table S158. Gene #40: 'amp_17q25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 40(17Q25.1) MUTATED	101	67.3 (9.2)
AMP PEAK 40(17Q25.1) WILD-TYPE	425	63.2 (11.5)

Figure S158. Get High-res Image Gene #40: 'amp_17q25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_17q25.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S159. Gene #40: 'amp_17q25.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 40(17Q25.1) MUTATED	37	9	56
AMP PEAK 40(17Q25.1) WILD-TYPE	358	12	56

Figure S159. Get High-res Image Gene #40: 'amp_17q25.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_17q25.1' versus 'RACE'

P value = 8e-05 (Fisher's exact test), Q value = 4e-04

Table S160. Gene #40: 'amp_17q25.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 40(17Q25.1) MUTATED	0	0	36	2	59
AMP PEAK 40(17Q25.1) WILD-TYPE	4	20	65	7	307

Figure S160. Get High-res Image Gene #40: 'amp_17q25.1' versus Clinical Feature #6: 'RACE'

'amp_18p11.31' versus 'Time to Death'

P value = 0.00693 (logrank test), Q value = 0.018

Table S161. Gene #41: 'amp_18p11.31' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 41(18P11.31) MUTATED	94	21	0.4 - 125.4 (23.8)
AMP PEAK 41(18P11.31) WILD-TYPE	432	48	0.1 - 191.8 (23.3)

Figure S161. Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #1: 'Time to Death'

'amp_18p11.31' versus 'YEARS_TO_BIRTH'

P value = 8.63e-05 (Wilcoxon-test), Q value = 0.00042

Table S162. Gene #41: 'amp_18p11.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 41(18P11.31) MUTATED	93	67.9 (9.1)
AMP PEAK 41(18P11.31) WILD-TYPE	433	63.2 (11.5)

Figure S162. Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_18p11.31' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S163. Gene #41: 'amp_18p11.31' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 41(18P11.31) MUTATED	29	6	59
AMP PEAK 41(18P11.31) WILD-TYPE	366	15	53

Figure S163. Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_18p11.31' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0204 (Fisher's exact test), Q value = 0.045

Table S164. Gene #41: 'amp_18p11.31' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 41(18P11.31) MUTATED	16	78
AMP PEAK 41(18P11.31) WILD-TYPE	125	309

Figure S164. Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_18p11.31' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0266 (Fisher's exact test), Q value = 0.057

Table S165. Gene #41: 'amp_18p11.31' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
AMP PEAK 41(18P11.31) MUTATED	61	3	8	7
AMP PEAK 41(18P11.31) WILD-TYPE	302	20	9	28

Figure S165. Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_18p11.31' versus 'RACE'

P value = 0.00112 (Fisher's exact test), Q value = 0.0039

Table S166. Gene #41: 'amp_18p11.31' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 41(18P11.31) MUTATED	0	3	33	1	52
AMP PEAK 41(18P11.31) WILD-TYPE	4	17	68	8	314

Figure S166. Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #6: 'RACE'

'amp_18q11.2' versus 'Time to Death'

P value = 0.00841 (logrank test), Q value = 0.021

Table S167. Gene #42: 'amp_18q11.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 42(18Q11.2) MUTATED	68	17	1.4 - 125.4 (27.1)
AMP PEAK 42(18Q11.2) WILD-TYPE	458	52	0.1 - 191.8 (22.9)

Figure S167. Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #1: 'Time to Death'

'amp_18q11.2' versus 'YEARS_TO_BIRTH'

P value = 0.00197 (Wilcoxon-test), Q value = 0.0062

Table S168. Gene #42: 'amp_18q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 42(18Q11.2) MUTATED	67	67.9 (10.1)
AMP PEAK 42(18Q11.2) WILD-TYPE	459	63.4 (11.3)

Figure S168. Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_18q11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S169. Gene #42: 'amp_18q11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 42(18Q11.2) MUTATED	20	4	44
AMP PEAK 42(18Q11.2) WILD-TYPE	375	17	68

Figure S169. Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_18q11.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0755 (Fisher's exact test), Q value = 0.14

Table S170. Gene #42: 'amp_18q11.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
AMP PEAK 42(18Q11.2) MUTATED	43	1	4	8
AMP PEAK 42(18Q11.2) WILD-TYPE	320	22	13	27

Figure S170. Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_18q11.2' versus 'RACE'

P value = 0.00519 (Fisher's exact test), Q value = 0.014

Table S171. Gene #42: 'amp_18q11.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 42(18Q11.2) MUTATED	0	1	25	1	38
AMP PEAK 42(18Q11.2) WILD-TYPE	4	19	76	8	328

Figure S171. Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #6: 'RACE'

'amp_19p13.2' versus 'Time to Death'

P value = 0.0128 (logrank test), Q value = 0.03

Table S172. Gene #43: 'amp_19p13.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 43(19P13.2) MUTATED	96	20	0.1 - 125.4 (23.1)
AMP PEAK 43(19P13.2) WILD-TYPE	430	49	0.1 - 191.8 (23.3)

Figure S172. Get High-res Image Gene #43: 'amp_19p13.2' versus Clinical Feature #1: 'Time to Death'

'amp_19p13.2' versus 'YEARS_TO_BIRTH'

P value = 4.56e-10 (Wilcoxon-test), Q value = 9.4e-08

Table S173. Gene #43: 'amp_19p13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 43(19P13.2) MUTATED	96	70.2 (8.6)
AMP PEAK 43(19P13.2) WILD-TYPE	430	62.6 (11.3)

Figure S173. Get High-res Image Gene #43: 'amp_19p13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_19p13.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S174. Gene #43: 'amp_19p13.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 43(19P13.2) MUTATED	26	7	64
AMP PEAK 43(19P13.2) WILD-TYPE	369	14	48

Figure S174. Get High-res Image Gene #43: 'amp_19p13.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_19p13.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0561 (Fisher's exact test), Q value = 0.11

Table S175. Gene #43: 'amp_19p13.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 43(19P13.2) MUTATED	18	79
AMP PEAK 43(19P13.2) WILD-TYPE	123	308

Figure S175. Get High-res Image Gene #43: 'amp_19p13.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_19p13.2' versus 'RACE'

P value = 0.00133 (Fisher's exact test), Q value = 0.0044

Table S176. Gene #43: 'amp_19p13.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 43(19P13.2) MUTATED	0	0	31	2	58
AMP PEAK 43(19P13.2) WILD-TYPE	4	20	70	7	308

Figure S176. Get High-res Image Gene #43: 'amp_19p13.2' versus Clinical Feature #6: 'RACE'

'amp_19q12' versus 'Time to Death'

P value = 4.99e-05 (logrank test), Q value = 0.00026

Table S177. Gene #44: 'amp_19q12' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 44(19Q12) MUTATED	115	27	0.1 - 125.4 (20.5)
AMP PEAK 44(19Q12) WILD-TYPE	411	42	0.2 - 191.8 (23.9)

Figure S177. Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #1: 'Time to Death'

'amp_19q12' versus 'YEARS_TO_BIRTH'

P value = 1.44e-08 (Wilcoxon-test), Q value = 1e-06

Table S178. Gene #44: 'amp_19q12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 44(19Q12) MUTATED	115	68.9 (8.6)
AMP PEAK 44(19Q12) WILD-TYPE	411	62.6 (11.5)

Figure S178. Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_19q12' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S179. Gene #44: 'amp_19q12' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 44(19Q12) MUTATED	29	10	77
AMP PEAK 44(19Q12) WILD-TYPE	366	11	35

Figure S179. Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_19q12' versus 'RACE'

P value = 3e-05 (Fisher's exact test), Q value = 0.00016

Table S180. Gene #44: 'amp_19q12' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 44(19Q12) MUTATED	1	2	43	3	62
AMP PEAK 44(19Q12) WILD-TYPE	3	18	58	6	304

Figure S180. Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #6: 'RACE'

'amp_20p13' versus 'YEARS_TO_BIRTH'

P value = 2.37e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S181. Gene #45: 'amp_20p13' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 45(20P13) MUTATED	116	67.8 (10.8)
AMP PEAK 45(20P13) WILD-TYPE	410	62.9 (11.1)

Figure S181. Get High-res Image Gene #45: 'amp_20p13' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_20p13' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S182. Gene #45: 'amp_20p13' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 45(20P13) MUTATED	52	5	59
AMP PEAK 45(20P13) WILD-TYPE	343	16	53

Figure S182. Get High-res Image Gene #45: 'amp_20p13' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_20p13' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.033 (Fisher's exact test), Q value = 0.068

Table S183. Gene #45: 'amp_20p13' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 45(20P13) MUTATED	22	94
AMP PEAK 45(20P13) WILD-TYPE	119	293

Figure S183. Get High-res Image Gene #45: 'amp_20p13' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_20p13' versus 'RACE'

P value = 0.0445 (Fisher's exact test), Q value = 0.088

Table S184. Gene #45: 'amp_20p13' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 45(20P13) MUTATED	0	4	33	2	69
AMP PEAK 45(20P13) WILD-TYPE	4	16	68	7	297

Figure S184. Get High-res Image Gene #45: 'amp_20p13' versus Clinical Feature #6: 'RACE'

'amp_20q11.21' versus 'Time to Death'

P value = 0.000289 (logrank test), Q value = 0.0012

Table S185. Gene #46: 'amp_20q11.21' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 46(20Q11.21) MUTATED	148	31	0.1 - 149.6 (20.4)
AMP PEAK 46(20Q11.21) WILD-TYPE	378	38	0.1 - 191.8 (23.8)

Figure S185. Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #1: 'Time to Death'

'amp_20q11.21' versus 'YEARS_TO_BIRTH'

P value = 1.88e-08 (Wilcoxon-test), Q value = 1.2e-06

Table S186. Gene #46: 'amp_20q11.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 46(20Q11.21) MUTATED	149	68.1 (9.7)
AMP PEAK 46(20Q11.21) WILD-TYPE	377	62.4 (11.4)

Figure S186. Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_20q11.21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S187. Gene #46: 'amp_20q11.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 46(20Q11.21) MUTATED	62	6	81
AMP PEAK 46(20Q11.21) WILD-TYPE	333	15	31

Figure S187. Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_20q11.21' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00612 (Fisher's exact test), Q value = 0.016

Table S188. Gene #46: 'amp_20q11.21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 46(20Q11.21) MUTATED	27	122
AMP PEAK 46(20Q11.21) WILD-TYPE	114	265

Figure S188. Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_20q11.21' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.106 (Fisher's exact test), Q value = 0.18

Table S189. Gene #46: 'amp_20q11.21' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
AMP PEAK 46(20Q11.21) MUTATED	93	5	9	10
AMP PEAK 46(20Q11.21) WILD-TYPE	270	18	8	25

Figure S189. Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_20q11.21' versus 'RACE'

P value = 0.00654 (Fisher's exact test), Q value = 0.017

Table S190. Gene #46: 'amp_20q11.21' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 46(20Q11.21) MUTATED	1	5	43	3	88
AMP PEAK 46(20Q11.21) WILD-TYPE	3	15	58	6	278

Figure S190. Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #6: 'RACE'

'amp_20q13.12' versus 'Time to Death'

P value = 0.00947 (logrank test), Q value = 0.023

Table S191. Gene #47: 'amp_20q13.12' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 47(20Q13.12) MUTATED	148	28	0.1 - 191.8 (20.4)
AMP PEAK 47(20Q13.12) WILD-TYPE	378	41	0.1 - 185.8 (23.7)

Figure S191. Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #1: 'Time to Death'

'amp_20q13.12' versus 'YEARS_TO_BIRTH'

P value = 1.34e-08 (Wilcoxon-test), Q value = 1e-06

Table S192. Gene #47: 'amp_20q13.12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 47(20Q13.12) MUTATED	148	68.3 (10.0)
AMP PEAK 47(20Q13.12) WILD-TYPE	378	62.3 (11.2)

Figure S192. Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_20q13.12' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S193. Gene #47: 'amp_20q13.12' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 47(20Q13.12) MUTATED	64	7	78
AMP PEAK 47(20Q13.12) WILD-TYPE	331	14	34

Figure S193. Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_20q13.12' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00104 (Fisher's exact test), Q value = 0.0037

Table S194. Gene #47: 'amp_20q13.12' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 47(20Q13.12) MUTATED	25	124
AMP PEAK 47(20Q13.12) WILD-TYPE	116	263

Figure S194. Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_20q13.12' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0596 (Fisher's exact test), Q value = 0.11

Table S195. Gene #47: 'amp_20q13.12' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
AMP PEAK 47(20Q13.12) MUTATED	91	7	9	12
AMP PEAK 47(20Q13.12) WILD-TYPE	272	16	8	23

Figure S195. Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_20q13.12' versus 'RACE'

P value = 0.00522 (Fisher's exact test), Q value = 0.014

Table S196. Gene #47: 'amp_20q13.12' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 47(20Q13.12) MUTATED	1	5	43	3	87
AMP PEAK 47(20Q13.12) WILD-TYPE	3	15	58	6	279

Figure S196. Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #6: 'RACE'

'amp_20q13.33' versus 'Time to Death'

P value = 0.014 (logrank test), Q value = 0.033

Table S197. Gene #48: 'amp_20q13.33' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 48(20Q13.33) MUTATED	149	28	0.1 - 191.8 (20.3)
AMP PEAK 48(20Q13.33) WILD-TYPE	377	41	0.1 - 185.8 (23.9)

Figure S197. Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #1: 'Time to Death'

'amp_20q13.33' versus 'YEARS_TO_BIRTH'

P value = 3.51e-08 (Wilcoxon-test), Q value = 1.8e-06

Table S198. Gene #48: 'amp_20q13.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 48(20Q13.33) MUTATED	149	68.1 (10.3)
AMP PEAK 48(20Q13.33) WILD-TYPE	377	62.4 (11.2)

Figure S198. Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_20q13.33' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S199. Gene #48: 'amp_20q13.33' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 48(20Q13.33) MUTATED	67	6	77
AMP PEAK 48(20Q13.33) WILD-TYPE	328	15	35

Figure S199. Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_20q13.33' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00101 (Fisher's exact test), Q value = 0.0036

Table S200. Gene #48: 'amp_20q13.33' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 48(20Q13.33) MUTATED	25	125
AMP PEAK 48(20Q13.33) WILD-TYPE	116	262

Figure S200. Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_20q13.33' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0133 (Fisher's exact test), Q value = 0.031

Table S201. Gene #48: 'amp_20q13.33' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
AMP PEAK 48(20Q13.33) MUTATED	91	7	10	13
AMP PEAK 48(20Q13.33) WILD-TYPE	272	16	7	22

Figure S201. Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_20q13.33' versus 'RACE'

P value = 0.0395 (Fisher's exact test), Q value = 0.081

Table S202. Gene #48: 'amp_20q13.33' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 48(20Q13.33) MUTATED	1	6	41	3	92
AMP PEAK 48(20Q13.33) WILD-TYPE	3	14	60	6	274

Figure S202. Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #6: 'RACE'

'amp_22q12.2' versus 'Time to Death'

P value = 0.000495 (logrank test), Q value = 0.0019

Table S203. Gene #49: 'amp_22q12.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 49(22Q12.2) MUTATED	61	17	0.4 - 191.8 (21.9)
AMP PEAK 49(22Q12.2) WILD-TYPE	465	52	0.1 - 185.8 (23.3)

Figure S203. Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #1: 'Time to Death'

'amp_22q12.2' versus 'YEARS_TO_BIRTH'

P value = 0.000572 (Wilcoxon-test), Q value = 0.0021

Table S204. Gene #49: 'amp_22q12.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 49(22Q12.2) MUTATED	61	68.3 (10.1)
AMP PEAK 49(22Q12.2) WILD-TYPE	465	63.4 (11.2)

Figure S204. Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_22q12.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S205. Gene #49: 'amp_22q12.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 49(22Q12.2) MUTATED	11	2	49
AMP PEAK 49(22Q12.2) WILD-TYPE	384	19	63

Figure S205. Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_22q12.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0474 (Fisher's exact test), Q value = 0.093

Table S206. Gene #49: 'amp_22q12.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 49(22Q12.2) MUTATED	10	52
AMP PEAK 49(22Q12.2) WILD-TYPE	131	335

Figure S206. Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_22q12.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.00228 (Fisher's exact test), Q value = 0.0071

Table S207. Gene #49: 'amp_22q12.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
AMP PEAK 49(22Q12.2) MUTATED	35	3	7	6
AMP PEAK 49(22Q12.2) WILD-TYPE	328	20	10	29

Figure S207. Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'amp_22q12.2' versus 'RACE'

P value = 0.0256 (Fisher's exact test), Q value = 0.055

Table S208. Gene #49: 'amp_22q12.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
AMP PEAK 49(22Q12.2) MUTATED	0	1	21	0	34
AMP PEAK 49(22Q12.2) WILD-TYPE	4	19	80	9	332

Figure S208. Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #6: 'RACE'

'amp_xp11.23' versus 'Time to Death'

P value = 0.0887 (logrank test), Q value = 0.16

Table S209. Gene #50: 'amp_xp11.23' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 50(XP11.23) MUTATED	89	16	0.1 - 110.1 (22.6)
AMP PEAK 50(XP11.23) WILD-TYPE	437	53	0.2 - 191.8 (23.4)

Figure S209. Get High-res Image Gene #50: 'amp_xp11.23' versus Clinical Feature #1: 'Time to Death'

'amp_xp11.23' versus 'YEARS_TO_BIRTH'

P value = 0.029 (Wilcoxon-test), Q value = 0.061

Table S210. Gene #50: 'amp_xp11.23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 50(XP11.23) MUTATED	89	66.2 (11.2)
AMP PEAK 50(XP11.23) WILD-TYPE	437	63.6 (11.2)

Figure S210. Get High-res Image Gene #50: 'amp_xp11.23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_xp11.23' versus 'HISTOLOGICAL_TYPE'

P value = 0.00034 (Fisher's exact test), Q value = 0.0013

Table S211. Gene #50: 'amp_xp11.23' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 50(XP11.23) MUTATED	52	4	33
AMP PEAK 50(XP11.23) WILD-TYPE	343	17	79

Figure S211. Get High-res Image Gene #50: 'amp_xp11.23' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'amp_xp11.23' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.025 (Fisher's exact test), Q value = 0.054

Table S212. Gene #50: 'amp_xp11.23' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
AMP PEAK 50(XP11.23) MUTATED	15	74
AMP PEAK 50(XP11.23) WILD-TYPE	126	313

Figure S212. Get High-res Image Gene #50: 'amp_xp11.23' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'amp_xq28' versus 'Time to Death'

P value = 0.000466 (logrank test), Q value = 0.0018

Table S213. Gene #51: 'amp_xq28' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
AMP PEAK 51(XQ28) MUTATED	88	21	0.1 - 110.1 (22.2)
AMP PEAK 51(XQ28) WILD-TYPE	438	48	0.1 - 191.8 (23.4)

Figure S213. Get High-res Image Gene #51: 'amp_xq28' versus Clinical Feature #1: 'Time to Death'

'amp_xq28' versus 'YEARS_TO_BIRTH'

P value = 0.0513 (Wilcoxon-test), Q value = 0.099

Table S214. Gene #51: 'amp_xq28' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
AMP PEAK 51(XQ28) MUTATED	88	66.1 (12.3)
AMP PEAK 51(XQ28) WILD-TYPE	438	63.6 (11.0)

Figure S214. Get High-res Image Gene #51: 'amp_xq28' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_xq28' versus 'HISTOLOGICAL_TYPE'

P value = 0.00059 (Fisher's exact test), Q value = 0.0022

Table S215. Gene #51: 'amp_xq28' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
AMP PEAK 51(XQ28) MUTATED	53	3	33
AMP PEAK 51(XQ28) WILD-TYPE	342	18	79

Figure S215. Get High-res Image Gene #51: 'amp_xq28' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_1p36.21' versus 'YEARS_TO_BIRTH'

P value = 0.000199 (Wilcoxon-test), Q value = 0.00086

Table S216. Gene #52: 'del_1p36.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 1(1P36.21) MUTATED	69	69.1 (10.2)
DEL PEAK 1(1P36.21) WILD-TYPE	457	63.2 (11.2)

Figure S216. Get High-res Image Gene #52: 'del_1p36.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_1p36.21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S217. Gene #52: 'del_1p36.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 1(1P36.21) MUTATED	26	5	38
DEL PEAK 1(1P36.21) WILD-TYPE	369	16	74

Figure S217. Get High-res Image Gene #52: 'del_1p36.21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_1p36.11' versus 'Time to Death'

P value = 0.00773 (logrank test), Q value = 0.02

Table S218. Gene #53: 'del_1p36.11' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 2(1P36.11) MUTATED	78	17	0.4 - 149.6 (20.5)
DEL PEAK 2(1P36.11) WILD-TYPE	448	52	0.1 - 191.8 (23.4)

Figure S218. Get High-res Image Gene #53: 'del_1p36.11' versus Clinical Feature #1: 'Time to Death'

'del_1p36.11' versus 'YEARS_TO_BIRTH'

P value = 9.85e-05 (Wilcoxon-test), Q value = 0.00047

Table S219. Gene #53: 'del_1p36.11' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 2(1P36.11) MUTATED	79	68.7 (9.4)
DEL PEAK 2(1P36.11) WILD-TYPE	447	63.2 (11.3)

Figure S219. Get High-res Image Gene #53: 'del_1p36.11' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_1p36.11' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S220. Gene #53: 'del_1p36.11' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 2(1P36.11) MUTATED	25	5	49
DEL PEAK 2(1P36.11) WILD-TYPE	370	16	63

Figure S220. Get High-res Image Gene #53: 'del_1p36.11' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_1p36.11' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0421 (Fisher's exact test), Q value = 0.085

Table S221. Gene #53: 'del_1p36.11' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 2(1P36.11) MUTATED	52	7	5	3
DEL PEAK 2(1P36.11) WILD-TYPE	311	16	12	32

Figure S221. Get High-res Image Gene #53: 'del_1p36.11' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_2p25.3' versus 'Time to Death'

P value = 0.0429 (logrank test), Q value = 0.086

Table S222. Gene #54: 'del_2p25.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 3(2P25.3) MUTATED	25	6	0.6 - 125.4 (18.9)
DEL PEAK 3(2P25.3) WILD-TYPE	501	63	0.1 - 191.8 (23.7)

Figure S222. Get High-res Image Gene #54: 'del_2p25.3' versus Clinical Feature #1: 'Time to Death'

'del_2p25.3' versus 'YEARS_TO_BIRTH'

P value = 0.071 (Wilcoxon-test), Q value = 0.13

Table S223. Gene #54: 'del_2p25.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 3(2P25.3) MUTATED	26	66.8 (7.9)
DEL PEAK 3(2P25.3) WILD-TYPE	500	63.9 (11.4)

Figure S223. Get High-res Image Gene #54: 'del_2p25.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_2p25.3' versus 'HISTOLOGICAL_TYPE'

P value = 0.0104 (Fisher's exact test), Q value = 0.025

Table S224. Gene #54: 'del_2p25.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 3(2P25.3) MUTATED	13	2	11
DEL PEAK 3(2P25.3) WILD-TYPE	382	19	101

Figure S224. Get High-res Image Gene #54: 'del_2p25.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_2p25.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.109 (Fisher's exact test), Q value = 0.19

Table S225. Gene #54: 'del_2p25.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 3(2P25.3) MUTATED	3	23
DEL PEAK 3(2P25.3) WILD-TYPE	138	364

Figure S225. Get High-res Image Gene #54: 'del_2p25.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_2q22.1' versus 'Time to Death'

P value = 1.26e-07 (logrank test), Q value = 5.2e-06

Table S226. Gene #55: 'del_2q22.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 4(2Q22.1) MUTATED	46	16	0.6 - 125.4 (16.9)
DEL PEAK 4(2Q22.1) WILD-TYPE	480	53	0.1 - 191.8 (23.9)

Figure S226. Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #1: 'Time to Death'

'del_2q22.1' versus 'YEARS_TO_BIRTH'

P value = 0.0048 (Wilcoxon-test), Q value = 0.013

Table S227. Gene #55: 'del_2q22.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 4(2Q22.1) MUTATED	46	68.0 (9.3)
DEL PEAK 4(2Q22.1) WILD-TYPE	480	63.6 (11.3)

Figure S227. Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_2q22.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S228. Gene #55: 'del_2q22.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 4(2Q22.1) MUTATED	17	2	27
DEL PEAK 4(2Q22.1) WILD-TYPE	378	19	85

Figure S228. Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_2q22.1' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0027 (Fisher's exact test), Q value = 0.0081

Table S229. Gene #55: 'del_2q22.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 4(2Q22.1) MUTATED	4	42
DEL PEAK 4(2Q22.1) WILD-TYPE	137	345

Figure S229. Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_2q22.1' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.00162 (Fisher's exact test), Q value = 0.0052

Table S230. Gene #55: 'del_2q22.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 4(2Q22.1) MUTATED	24	2	5	7
DEL PEAK 4(2Q22.1) WILD-TYPE	339	21	12	28

Figure S230. Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_2q22.1' versus 'RACE'

P value = 0.0849 (Fisher's exact test), Q value = 0.15

Table S231. Gene #55: 'del_2q22.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 4(2Q22.1) MUTATED	0	1	16	1	26
DEL PEAK 4(2Q22.1) WILD-TYPE	4	19	85	8	340

Figure S231. Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #6: 'RACE'

'del_2q37.3' versus 'Time to Death'

P value = 0.0185 (logrank test), Q value = 0.041

Table S232. Gene #56: 'del_2q37.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 5(2Q37.3) MUTATED	51	12	0.6 - 102.3 (22.3)
DEL PEAK 5(2Q37.3) WILD-TYPE	475	57	0.1 - 191.8 (23.3)

Figure S232. Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #1: 'Time to Death'

'del_2q37.3' versus 'YEARS_TO_BIRTH'

P value = 0.00257 (Wilcoxon-test), Q value = 0.0079

Table S233. Gene #56: 'del_2q37.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 5(2Q37.3) MUTATED	52	68.2 (8.4)
DEL PEAK 5(2Q37.3) WILD-TYPE	474	63.5 (11.4)

Figure S233. Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_2q37.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-04 (Fisher's exact test), Q value = 0.00047

Table S234. Gene #56: 'del_2q37.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 5(2Q37.3) MUTATED	26	2	24
DEL PEAK 5(2Q37.3) WILD-TYPE	369	19	88

Figure S234. Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_2q37.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.137 (Fisher's exact test), Q value = 0.22

Table S235. Gene #56: 'del_2q37.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 5(2Q37.3) MUTATED	9	43
DEL PEAK 5(2Q37.3) WILD-TYPE	132	344

Figure S235. Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_2q37.3' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0439 (Fisher's exact test), Q value = 0.087

Table S236. Gene #56: 'del_2q37.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 5(2Q37.3) MUTATED	32	2	3	8
DEL PEAK 5(2Q37.3) WILD-TYPE	331	21	14	27

Figure S236. Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_2q37.3' versus 'RACE'

P value = 0.142 (Fisher's exact test), Q value = 0.23

Table S237. Gene #56: 'del_2q37.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 5(2Q37.3) MUTATED	0	0	14	2	32
DEL PEAK 5(2Q37.3) WILD-TYPE	4	20	87	7	334

Figure S237. Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #6: 'RACE'

'del_3p14.2' versus 'YEARS_TO_BIRTH'

P value = 0.00112 (Wilcoxon-test), Q value = 0.0039

Table S238. Gene #57: 'del_3p14.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 6(3P14.2) MUTATED	76	67.5 (8.0)
DEL PEAK 6(3P14.2) WILD-TYPE	450	63.4 (11.6)

Figure S238. Get High-res Image Gene #57: 'del_3p14.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_3p14.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S239. Gene #57: 'del_3p14.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 6(3P14.2) MUTATED	27	6	44
DEL PEAK 6(3P14.2) WILD-TYPE	368	15	68

Figure S239. Get High-res Image Gene #57: 'del_3p14.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_3p14.2' versus 'RACE'

P value = 0.022 (Fisher's exact test), Q value = 0.048

Table S240. Gene #57: 'del_3p14.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 6(3P14.2) MUTATED	0	1	25	0	47
DEL PEAK 6(3P14.2) WILD-TYPE	4	19	76	9	319

Figure S240. Get High-res Image Gene #57: 'del_3p14.2' versus Clinical Feature #6: 'RACE'

'del_3p14.2' versus 'ETHNICITY'

P value = 0.141 (Fisher's exact test), Q value = 0.23

Table S241. Gene #57: 'del_3p14.2' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	14	367
DEL PEAK 6(3P14.2) MUTATED	0	58
DEL PEAK 6(3P14.2) WILD-TYPE	14	309

Figure S241. Get High-res Image Gene #57: 'del_3p14.2' versus Clinical Feature #7: 'ETHNICITY'

'del_3q13.31' versus 'YEARS_TO_BIRTH'

P value = 0.000389 (Wilcoxon-test), Q value = 0.0015

Table S242. Gene #58: 'del_3q13.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 7(3Q13.31) MUTATED	42	69.4 (10.2)
DEL PEAK 7(3Q13.31) WILD-TYPE	484	63.5 (11.2)

Figure S242. Get High-res Image Gene #58: 'del_3q13.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_3q13.31' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S243. Gene #58: 'del_3q13.31' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 7(3Q13.31) MUTATED	17	3	22
DEL PEAK 7(3Q13.31) WILD-TYPE	378	18	90

Figure S243. Get High-res Image Gene #58: 'del_3q13.31' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_4p16.3' versus 'Time to Death'

P value = 0.00202 (logrank test), Q value = 0.0063

Table S244. Gene #59: 'del_4p16.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 8(4P16.3) MUTATED	88	19	0.2 - 149.6 (20.0)
DEL PEAK 8(4P16.3) WILD-TYPE	438	50	0.1 - 191.8 (23.9)

Figure S244. Get High-res Image Gene #59: 'del_4p16.3' versus Clinical Feature #1: 'Time to Death'

'del_4p16.3' versus 'YEARS_TO_BIRTH'

P value = 0.000181 (Wilcoxon-test), Q value = 8e-04

Table S245. Gene #59: 'del_4p16.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 8(4P16.3) MUTATED	89	68.0 (9.0)
DEL PEAK 8(4P16.3) WILD-TYPE	437	63.2 (11.5)

Figure S245. Get High-res Image Gene #59: 'del_4p16.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_4p16.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S246. Gene #59: 'del_4p16.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 8(4P16.3) MUTATED	29	5	55
DEL PEAK 8(4P16.3) WILD-TYPE	366	16	57

Figure S246. Get High-res Image Gene #59: 'del_4p16.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_4p15.2' versus 'Time to Death'

P value = 0.00057 (logrank test), Q value = 0.0021

Table S247. Gene #60: 'del_4p15.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 9(4P15.2) MUTATED	92	21	0.2 - 149.6 (20.0)
DEL PEAK 9(4P15.2) WILD-TYPE	434	48	0.1 - 191.8 (23.9)

Figure S247. Get High-res Image Gene #60: 'del_4p15.2' versus Clinical Feature #1: 'Time to Death'

'del_4p15.2' versus 'YEARS_TO_BIRTH'

P value = 7.19e-05 (Wilcoxon-test), Q value = 0.00036

Table S248. Gene #60: 'del_4p15.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 9(4P15.2) MUTATED	93	68.2 (9.1)
DEL PEAK 9(4P15.2) WILD-TYPE	433	63.1 (11.4)

Figure S248. Get High-res Image Gene #60: 'del_4p15.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_4p15.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S249. Gene #60: 'del_4p15.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 9(4P15.2) MUTATED	31	5	57
DEL PEAK 9(4P15.2) WILD-TYPE	364	16	55

Figure S249. Get High-res Image Gene #60: 'del_4p15.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_4p15.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0929 (Fisher's exact test), Q value = 0.16

Table S250. Gene #60: 'del_4p15.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 9(4P15.2) MUTATED	18	75
DEL PEAK 9(4P15.2) WILD-TYPE	123	312

Figure S250. Get High-res Image Gene #60: 'del_4p15.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_4q22.1' versus 'Time to Death'

P value = 0.00539 (logrank test), Q value = 0.015

Table S251. Gene #61: 'del_4q22.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 10(4Q22.1) MUTATED	101	22	0.2 - 149.6 (21.2)
DEL PEAK 10(4Q22.1) WILD-TYPE	425	47	0.1 - 191.8 (23.5)

Figure S251. Get High-res Image Gene #61: 'del_4q22.1' versus Clinical Feature #1: 'Time to Death'

'del_4q22.1' versus 'YEARS_TO_BIRTH'

P value = 8e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S252. Gene #61: 'del_4q22.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 10(4Q22.1) MUTATED	102	68.3 (8.9)
DEL PEAK 10(4Q22.1) WILD-TYPE	424	63.0 (11.5)

Figure S252. Get High-res Image Gene #61: 'del_4q22.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_4q22.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S253. Gene #61: 'del_4q22.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 10(4Q22.1) MUTATED	30	6	66
DEL PEAK 10(4Q22.1) WILD-TYPE	365	15	46

Figure S253. Get High-res Image Gene #61: 'del_4q22.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_4q22.1' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.135 (Fisher's exact test), Q value = 0.22

Table S254. Gene #61: 'del_4q22.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 10(4Q22.1) MUTATED	21	81
DEL PEAK 10(4Q22.1) WILD-TYPE	120	306

Figure S254. Get High-res Image Gene #61: 'del_4q22.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_4q22.1' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0787 (Fisher's exact test), Q value = 0.14

Table S255. Gene #61: 'del_4q22.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 10(4Q22.1) MUTATED	63	6	7	7
DEL PEAK 10(4Q22.1) WILD-TYPE	300	17	10	28

Figure S255. Get High-res Image Gene #61: 'del_4q22.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_4q34.3' versus 'Time to Death'

P value = 0.00667 (logrank test), Q value = 0.017

Table S256. Gene #62: 'del_4q34.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 11(4Q34.3) MUTATED	126	25	0.2 - 149.6 (20.8)
DEL PEAK 11(4Q34.3) WILD-TYPE	400	44	0.1 - 191.8 (23.7)

Figure S256. Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #1: 'Time to Death'

'del_4q34.3' versus 'YEARS_TO_BIRTH'

P value = 6.72e-07 (Wilcoxon-test), Q value = 2.4e-05

Table S257. Gene #62: 'del_4q34.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 11(4Q34.3) MUTATED	127	68.0 (9.8)
DEL PEAK 11(4Q34.3) WILD-TYPE	399	62.7 (11.4)

Figure S257. Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_4q34.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S258. Gene #62: 'del_4q34.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 11(4Q34.3) MUTATED	43	8	76
DEL PEAK 11(4Q34.3) WILD-TYPE	352	13	36

Figure S258. Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_4q34.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.134 (Fisher's exact test), Q value = 0.22

Table S259. Gene #62: 'del_4q34.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 11(4Q34.3) MUTATED	27	100
DEL PEAK 11(4Q34.3) WILD-TYPE	114	287

Figure S259. Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_4q34.3' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.137 (Fisher's exact test), Q value = 0.22

Table S260. Gene #62: 'del_4q34.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 11(4Q34.3) MUTATED	81	6	8	7
DEL PEAK 11(4Q34.3) WILD-TYPE	282	17	9	28

Figure S260. Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_4q34.3' versus 'RACE'

P value = 0.0115 (Fisher's exact test), Q value = 0.028

Table S261. Gene #62: 'del_4q34.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 11(4Q34.3) MUTATED	0	4	37	3	75
DEL PEAK 11(4Q34.3) WILD-TYPE	4	16	64	6	291

Figure S261. Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #6: 'RACE'

'del_5q12.1' versus 'Time to Death'

P value = 0.00485 (logrank test), Q value = 0.013

Table S262. Gene #63: 'del_5q12.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 12(5Q12.1) MUTATED	108	23	0.2 - 149.6 (22.0)
DEL PEAK 12(5Q12.1) WILD-TYPE	418	46	0.1 - 191.8 (23.6)

Figure S262. Get High-res Image Gene #63: 'del_5q12.1' versus Clinical Feature #1: 'Time to Death'

'del_5q12.1' versus 'YEARS_TO_BIRTH'

P value = 6.11e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S263. Gene #63: 'del_5q12.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 12(5Q12.1) MUTATED	108	67.9 (9.7)
DEL PEAK 12(5Q12.1) WILD-TYPE	418	63.0 (11.4)

Figure S263. Get High-res Image Gene #63: 'del_5q12.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_5q12.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S264. Gene #63: 'del_5q12.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 12(5Q12.1) MUTATED	35	4	70
DEL PEAK 12(5Q12.1) WILD-TYPE	360	17	42

Figure S264. Get High-res Image Gene #63: 'del_5q12.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_5q12.1' versus 'RACE'

P value = 0.0747 (Fisher's exact test), Q value = 0.14

Table S265. Gene #63: 'del_5q12.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 12(5Q12.1) MUTATED	0	3	29	3	64
DEL PEAK 12(5Q12.1) WILD-TYPE	4	17	72	6	302

Figure S265. Get High-res Image Gene #63: 'del_5q12.1' versus Clinical Feature #6: 'RACE'

'del_6q26' versus 'YEARS_TO_BIRTH'

P value = 0.00651 (Wilcoxon-test), Q value = 0.017

Table S266. Gene #64: 'del_6q26' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 13(6Q26) MUTATED	45	68.7 (11.1)
DEL PEAK 13(6Q26) WILD-TYPE	481	63.6 (11.1)

Figure S266. Get High-res Image Gene #64: 'del_6q26' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_6q26' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S267. Gene #64: 'del_6q26' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 13(6Q26) MUTATED	13	3	29
DEL PEAK 13(6Q26) WILD-TYPE	382	18	83

Figure S267. Get High-res Image Gene #64: 'del_6q26' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_7p22.3' versus 'Time to Death'

P value = 0.00112 (logrank test), Q value = 0.0039

Table S268. Gene #65: 'del_7p22.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 14(7P22.3) MUTATED	69	17	0.6 - 110.1 (23.2)
DEL PEAK 14(7P22.3) WILD-TYPE	457	52	0.1 - 191.8 (23.4)

Figure S268. Get High-res Image Gene #65: 'del_7p22.3' versus Clinical Feature #1: 'Time to Death'

'del_7p22.3' versus 'YEARS_TO_BIRTH'

P value = 6.52e-05 (Wilcoxon-test), Q value = 0.00034

Table S269. Gene #65: 'del_7p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 14(7P22.3) MUTATED	69	68.8 (10.1)
DEL PEAK 14(7P22.3) WILD-TYPE	457	63.3 (11.2)

Figure S269. Get High-res Image Gene #65: 'del_7p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_7p22.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S270. Gene #65: 'del_7p22.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 14(7P22.3) MUTATED	21	5	44
DEL PEAK 14(7P22.3) WILD-TYPE	374	16	68

Figure S270. Get High-res Image Gene #65: 'del_7p22.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_7p22.3' versus 'RACE'

P value = 0.119 (Fisher's exact test), Q value = 0.2

Table S271. Gene #65: 'del_7p22.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 14(7P22.3) MUTATED	0	2	21	1	40
DEL PEAK 14(7P22.3) WILD-TYPE	4	18	80	8	326

Figure S271. Get High-res Image Gene #65: 'del_7p22.3' versus Clinical Feature #6: 'RACE'

'del_7q11.22' versus 'YEARS_TO_BIRTH'

P value = 5.17e-05 (Wilcoxon-test), Q value = 0.00027

Table S272. Gene #66: 'del_7q11.22' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 15(7Q11.22) MUTATED	39	70.7 (9.8)
DEL PEAK 15(7Q11.22) WILD-TYPE	487	63.5 (11.2)

Figure S272. Get High-res Image Gene #66: 'del_7q11.22' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_7q11.22' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S273. Gene #66: 'del_7q11.22' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 15(7Q11.22) MUTATED	13	2	24
DEL PEAK 15(7Q11.22) WILD-TYPE	382	19	88

Figure S273. Get High-res Image Gene #66: 'del_7q11.22' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_7q31.1' versus 'Time to Death'

P value = 0.0267 (logrank test), Q value = 0.057

Table S274. Gene #67: 'del_7q31.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 16(7Q31.1) MUTATED	53	12	0.1 - 110.1 (22.1)
DEL PEAK 16(7Q31.1) WILD-TYPE	473	57	0.1 - 191.8 (23.5)

Figure S274. Get High-res Image Gene #67: 'del_7q31.1' versus Clinical Feature #1: 'Time to Death'

'del_7q31.1' versus 'YEARS_TO_BIRTH'

P value = 5.65e-05 (Wilcoxon-test), Q value = 3e-04

Table S275. Gene #67: 'del_7q31.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 16(7Q31.1) MUTATED	53	69.5 (7.8)
DEL PEAK 16(7Q31.1) WILD-TYPE	473	63.4 (11.4)

Figure S275. Get High-res Image Gene #67: 'del_7q31.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_7q31.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S276. Gene #67: 'del_7q31.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 16(7Q31.1) MUTATED	10	3	40
DEL PEAK 16(7Q31.1) WILD-TYPE	385	18	72

Figure S276. Get High-res Image Gene #67: 'del_7q31.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_7q31.1' versus 'RACE'

P value = 0.114 (Fisher's exact test), Q value = 0.19

Table S277. Gene #67: 'del_7q31.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 16(7Q31.1) MUTATED	0	0	16	1	31
DEL PEAK 16(7Q31.1) WILD-TYPE	4	20	85	8	335

Figure S277. Get High-res Image Gene #67: 'del_7q31.1' versus Clinical Feature #6: 'RACE'

'del_7q36.1' versus 'Time to Death'

P value = 0.00848 (logrank test), Q value = 0.021

Table S278. Gene #68: 'del_7q36.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 17(7Q36.1) MUTATED	62	15	1.2 - 125.4 (22.2)
DEL PEAK 17(7Q36.1) WILD-TYPE	464	54	0.1 - 191.8 (23.5)

Figure S278. Get High-res Image Gene #68: 'del_7q36.1' versus Clinical Feature #1: 'Time to Death'

'del_7q36.1' versus 'YEARS_TO_BIRTH'

P value = 3.24e-07 (Wilcoxon-test), Q value = 1.3e-05

Table S279. Gene #68: 'del_7q36.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 17(7Q36.1) MUTATED	62	70.6 (8.5)
DEL PEAK 17(7Q36.1) WILD-TYPE	464	63.1 (11.3)

Figure S279. Get High-res Image Gene #68: 'del_7q36.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_7q36.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S280. Gene #68: 'del_7q36.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 17(7Q36.1) MUTATED	12	4	46
DEL PEAK 17(7Q36.1) WILD-TYPE	383	17	66

Figure S280. Get High-res Image Gene #68: 'del_7q36.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_8p23.2' versus 'Time to Death'

P value = 0.000772 (logrank test), Q value = 0.0028

Table S281. Gene #69: 'del_8p23.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 18(8P23.2) MUTATED	113	26	0.3 - 191.8 (22.3)
DEL PEAK 18(8P23.2) WILD-TYPE	413	43	0.1 - 185.8 (23.5)

Figure S281. Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #1: 'Time to Death'

'del_8p23.2' versus 'YEARS_TO_BIRTH'

P value = 2.17e-05 (Wilcoxon-test), Q value = 0.00012

Table S282. Gene #69: 'del_8p23.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 18(8P23.2) MUTATED	113	67.6 (9.2)
DEL PEAK 18(8P23.2) WILD-TYPE	413	63.0 (11.5)

Figure S282. Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_8p23.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S283. Gene #69: 'del_8p23.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 18(8P23.2) MUTATED	34	5	76
DEL PEAK 18(8P23.2) WILD-TYPE	361	16	36

Figure S283. Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_8p23.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.122 (Fisher's exact test), Q value = 0.2

Table S284. Gene #69: 'del_8p23.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 18(8P23.2) MUTATED	24	91
DEL PEAK 18(8P23.2) WILD-TYPE	117	296

Figure S284. Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_8p23.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0585 (Fisher's exact test), Q value = 0.11

Table S285. Gene #69: 'del_8p23.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 18(8P23.2) MUTATED	69	5	7	11
DEL PEAK 18(8P23.2) WILD-TYPE	294	18	10	24

Figure S285. Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_8p23.2' versus 'RACE'

P value = 0.00564 (Fisher's exact test), Q value = 0.015

Table S286. Gene #69: 'del_8p23.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 18(8P23.2) MUTATED	1	2	35	2	67
DEL PEAK 18(8P23.2) WILD-TYPE	3	18	66	7	299

Figure S286. Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #6: 'RACE'

'del_8p21.2' versus 'Time to Death'

P value = 0.00679 (logrank test), Q value = 0.017

Table S287. Gene #70: 'del_8p21.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 19(8P21.2) MUTATED	112	24	0.3 - 191.8 (23.5)
DEL PEAK 19(8P21.2) WILD-TYPE	414	45	0.1 - 185.8 (23.3)

Figure S287. Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #1: 'Time to Death'

'del_8p21.2' versus 'YEARS_TO_BIRTH'

P value = 2.6e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S288. Gene #70: 'del_8p21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 19(8P21.2) MUTATED	112	68.1 (9.1)
DEL PEAK 19(8P21.2) WILD-TYPE	414	62.9 (11.5)

Figure S288. Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_8p21.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S289. Gene #70: 'del_8p21.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 19(8P21.2) MUTATED	26	6	81
DEL PEAK 19(8P21.2) WILD-TYPE	369	15	31

Figure S289. Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_8p21.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.151 (Fisher's exact test), Q value = 0.24

Table S290. Gene #70: 'del_8p21.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 19(8P21.2) MUTATED	24	89
DEL PEAK 19(8P21.2) WILD-TYPE	117	298

Figure S290. Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_8p21.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.146 (Fisher's exact test), Q value = 0.23

Table S291. Gene #70: 'del_8p21.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 19(8P21.2) MUTATED	70	5	7	9
DEL PEAK 19(8P21.2) WILD-TYPE	293	18	10	26

Figure S291. Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_8p21.2' versus 'RACE'

P value = 0.00731 (Fisher's exact test), Q value = 0.019

Table S292. Gene #70: 'del_8p21.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 19(8P21.2) MUTATED	1	2	34	2	65
DEL PEAK 19(8P21.2) WILD-TYPE	3	18	67	7	301

Figure S292. Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #6: 'RACE'

'del_9p23' versus 'Time to Death'

P value = 0.0163 (logrank test), Q value = 0.037

Table S293. Gene #71: 'del_9p23' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 20(9P23) MUTATED	76	17	0.3 - 149.6 (21.4)
DEL PEAK 20(9P23) WILD-TYPE	450	52	0.1 - 191.8 (23.5)

Figure S293. Get High-res Image Gene #71: 'del_9p23' versus Clinical Feature #1: 'Time to Death'

'del_9p23' versus 'YEARS_TO_BIRTH'

P value = 0.00143 (Wilcoxon-test), Q value = 0.0047

Table S294. Gene #71: 'del_9p23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 20(9P23) MUTATED	76	67.7 (9.2)
DEL PEAK 20(9P23) WILD-TYPE	450	63.4 (11.4)

Figure S294. Get High-res Image Gene #71: 'del_9p23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_9p23' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S295. Gene #71: 'del_9p23' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 20(9P23) MUTATED	28	4	44
DEL PEAK 20(9P23) WILD-TYPE	367	17	68

Figure S295. Get High-res Image Gene #71: 'del_9p23' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_9p23' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0491 (Fisher's exact test), Q value = 0.096

Table S296. Gene #71: 'del_9p23' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 20(9P23) MUTATED	13	63
DEL PEAK 20(9P23) WILD-TYPE	128	324

Figure S296. Get High-res Image Gene #71: 'del_9p23' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_9p23' versus 'RACE'

P value = 0.13 (Fisher's exact test), Q value = 0.21

Table S297. Gene #71: 'del_9p23' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 20(9P23) MUTATED	1	2	21	2	45
DEL PEAK 20(9P23) WILD-TYPE	3	18	80	7	321

Figure S297. Get High-res Image Gene #71: 'del_9p23' versus Clinical Feature #6: 'RACE'

'del_9q21.2' versus 'Time to Death'

P value = 1.41e-05 (logrank test), Q value = 8.1e-05

Table S298. Gene #72: 'del_9q21.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 21(9Q21.2) MUTATED	126	31	0.1 - 125.4 (21.9)
DEL PEAK 21(9Q21.2) WILD-TYPE	400	38	0.1 - 191.8 (23.7)

Figure S298. Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #1: 'Time to Death'

'del_9q21.2' versus 'YEARS_TO_BIRTH'

P value = 5.38e-10 (Wilcoxon-test), Q value = 9.4e-08

Table S299. Gene #72: 'del_9q21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 21(9Q21.2) MUTATED	125	69.2 (8.9)
DEL PEAK 21(9Q21.2) WILD-TYPE	401	62.4 (11.4)

Figure S299. Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_9q21.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S300. Gene #72: 'del_9q21.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 21(9Q21.2) MUTATED	49	10	67
DEL PEAK 21(9Q21.2) WILD-TYPE	346	11	45

Figure S300. Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_9q21.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.135 (Fisher's exact test), Q value = 0.22

Table S301. Gene #72: 'del_9q21.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 21(9Q21.2) MUTATED	27	99
DEL PEAK 21(9Q21.2) WILD-TYPE	114	288

Figure S301. Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_9q21.2' versus 'RACE'

P value = 0.0288 (Fisher's exact test), Q value = 0.061

Table S302. Gene #72: 'del_9q21.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 21(9Q21.2) MUTATED	1	1	34	2	81
DEL PEAK 21(9Q21.2) WILD-TYPE	3	19	67	7	285

Figure S302. Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #6: 'RACE'

'del_9q34.2' versus 'Time to Death'

P value = 0.000133 (logrank test), Q value = 0.00061

Table S303. Gene #73: 'del_9q34.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 22(9Q34.2) MUTATED	127	30	0.2 - 125.4 (23.7)
DEL PEAK 22(9Q34.2) WILD-TYPE	399	39	0.1 - 191.8 (23.3)

Figure S303. Get High-res Image Gene #73: 'del_9q34.2' versus Clinical Feature #1: 'Time to Death'

'del_9q34.2' versus 'YEARS_TO_BIRTH'

P value = 2.65e-08 (Wilcoxon-test), Q value = 1.4e-06

Table S304. Gene #73: 'del_9q34.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 22(9Q34.2) MUTATED	127	68.6 (8.5)
DEL PEAK 22(9Q34.2) WILD-TYPE	399	62.5 (11.6)

Figure S304. Get High-res Image Gene #73: 'del_9q34.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_9q34.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S305. Gene #73: 'del_9q34.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 22(9Q34.2) MUTATED	52	10	66
DEL PEAK 22(9Q34.2) WILD-TYPE	343	11	46

Figure S305. Get High-res Image Gene #73: 'del_9q34.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_9q34.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.109 (Fisher's exact test), Q value = 0.19

Table S306. Gene #73: 'del_9q34.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 22(9Q34.2) MUTATED	27	101
DEL PEAK 22(9Q34.2) WILD-TYPE	114	286

Figure S306. Get High-res Image Gene #73: 'del_9q34.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_10q23.31' versus 'Time to Death'

P value = 0.00423 (logrank test), Q value = 0.012

Table S307. Gene #74: 'del_10q23.31' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 23(10Q23.31) MUTATED	74	16	0.3 - 125.4 (18.8)
DEL PEAK 23(10Q23.31) WILD-TYPE	452	53	0.1 - 191.8 (23.7)

Figure S307. Get High-res Image Gene #74: 'del_10q23.31' versus Clinical Feature #1: 'Time to Death'

'del_10q23.31' versus 'YEARS_TO_BIRTH'

P value = 0.000879 (Wilcoxon-test), Q value = 0.0032

Table S308. Gene #74: 'del_10q23.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 23(10Q23.31) MUTATED	74	67.7 (9.7)
DEL PEAK 23(10Q23.31) WILD-TYPE	452	63.4 (11.3)

Figure S308. Get High-res Image Gene #74: 'del_10q23.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_10q23.31' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S309. Gene #74: 'del_10q23.31' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 23(10Q23.31) MUTATED	31	5	39
DEL PEAK 23(10Q23.31) WILD-TYPE	364	16	73

Figure S309. Get High-res Image Gene #74: 'del_10q23.31' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_10q23.31' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00452 (Fisher's exact test), Q value = 0.013

Table S310. Gene #74: 'del_10q23.31' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 23(10Q23.31) MUTATED	10	65
DEL PEAK 23(10Q23.31) WILD-TYPE	131	322

Figure S310. Get High-res Image Gene #74: 'del_10q23.31' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_11p15.5' versus 'Time to Death'

P value = 0.0163 (logrank test), Q value = 0.037

Table S311. Gene #75: 'del_11p15.5' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 24(11P15.5) MUTATED	101	20	0.1 - 149.6 (20.5)
DEL PEAK 24(11P15.5) WILD-TYPE	425	49	0.1 - 191.8 (23.7)

Figure S311. Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #1: 'Time to Death'

'del_11p15.5' versus 'YEARS_TO_BIRTH'

P value = 1.22e-05 (Wilcoxon-test), Q value = 7e-05

Table S312. Gene #75: 'del_11p15.5' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 24(11P15.5) MUTATED	101	68.2 (8.9)
DEL PEAK 24(11P15.5) WILD-TYPE	425	63.0 (11.5)

Figure S312. Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_11p15.5' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S313. Gene #75: 'del_11p15.5' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 24(11P15.5) MUTATED	36	5	61
DEL PEAK 24(11P15.5) WILD-TYPE	359	16	51

Figure S313. Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_11p15.5' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00584 (Fisher's exact test), Q value = 0.015

Table S314. Gene #75: 'del_11p15.5' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 24(11P15.5) MUTATED	16	86
DEL PEAK 24(11P15.5) WILD-TYPE	125	301

Figure S314. Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_11p15.5' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0897 (Fisher's exact test), Q value = 0.16

Table S315. Gene #75: 'del_11p15.5' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 24(11P15.5) MUTATED	63	3	7	8
DEL PEAK 24(11P15.5) WILD-TYPE	300	20	10	27

Figure S315. Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_11p15.5' versus 'RACE'

P value = 0.0548 (Fisher's exact test), Q value = 0.11

Table S316. Gene #75: 'del_11p15.5' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 24(11P15.5) MUTATED	1	3	30	1	62
DEL PEAK 24(11P15.5) WILD-TYPE	3	17	71	8	304

Figure S316. Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #6: 'RACE'

'del_11q14.1' versus 'Time to Death'

P value = 0.0903 (logrank test), Q value = 0.16

Table S317. Gene #76: 'del_11q14.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 25(11Q14.1) MUTATED	70	12	0.3 - 116.2 (19.6)
DEL PEAK 25(11Q14.1) WILD-TYPE	456	57	0.1 - 191.8 (23.8)

Figure S317. Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #1: 'Time to Death'

'del_11q14.1' versus 'YEARS_TO_BIRTH'

P value = 0.000288 (Wilcoxon-test), Q value = 0.0012

Table S318. Gene #76: 'del_11q14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 25(11Q14.1) MUTATED	70	68.6 (8.8)
DEL PEAK 25(11Q14.1) WILD-TYPE	456	63.3 (11.4)

Figure S318. Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_11q14.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S319. Gene #76: 'del_11q14.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 25(11Q14.1) MUTATED	21	6	43
DEL PEAK 25(11Q14.1) WILD-TYPE	374	15	69

Figure S319. Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_11q14.1' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0591 (Fisher's exact test), Q value = 0.11

Table S320. Gene #76: 'del_11q14.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 25(11Q14.1) MUTATED	12	58
DEL PEAK 25(11Q14.1) WILD-TYPE	129	329

Figure S320. Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_11q14.1' versus 'RACE'

P value = 0.0717 (Fisher's exact test), Q value = 0.13

Table S321. Gene #76: 'del_11q14.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 25(11Q14.1) MUTATED	1	2	21	0	41
DEL PEAK 25(11Q14.1) WILD-TYPE	3	18	80	9	325

Figure S321. Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #6: 'RACE'

'del_11q14.1' versus 'ETHNICITY'

P value = 0.0431 (Fisher's exact test), Q value = 0.086

Table S322. Gene #76: 'del_11q14.1' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	14	367
DEL PEAK 25(11Q14.1) MUTATED	5	52
DEL PEAK 25(11Q14.1) WILD-TYPE	9	315

Figure S322. Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #7: 'ETHNICITY'

'del_11q25' versus 'Time to Death'

P value = 0.00906 (logrank test), Q value = 0.022

Table S323. Gene #77: 'del_11q25' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 26(11Q25) MUTATED	92	18	0.3 - 116.2 (19.1)
DEL PEAK 26(11Q25) WILD-TYPE	434	51	0.1 - 191.8 (23.9)

Figure S323. Get High-res Image Gene #77: 'del_11q25' versus Clinical Feature #1: 'Time to Death'

'del_11q25' versus 'YEARS_TO_BIRTH'

P value = 0.000253 (Wilcoxon-test), Q value = 0.001

Table S324. Gene #77: 'del_11q25' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 26(11Q25) MUTATED	92	67.6 (9.7)
DEL PEAK 26(11Q25) WILD-TYPE	434	63.3 (11.4)

Figure S324. Get High-res Image Gene #77: 'del_11q25' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_11q25' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S325. Gene #77: 'del_11q25' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 26(11Q25) MUTATED	32	6	54
DEL PEAK 26(11Q25) WILD-TYPE	363	15	58

Figure S325. Get High-res Image Gene #77: 'del_11q25' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_11q25' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00266 (Fisher's exact test), Q value = 0.0081

Table S326. Gene #77: 'del_11q25' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 26(11Q25) MUTATED	13	79
DEL PEAK 26(11Q25) WILD-TYPE	128	308

Figure S326. Get High-res Image Gene #77: 'del_11q25' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_11q25' versus 'RACE'

P value = 0.0842 (Fisher's exact test), Q value = 0.15

Table S327. Gene #77: 'del_11q25' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 26(11Q25) MUTATED	1	2	26	1	54
DEL PEAK 26(11Q25) WILD-TYPE	3	18	75	8	312

Figure S327. Get High-res Image Gene #77: 'del_11q25' versus Clinical Feature #6: 'RACE'

'del_12q23.1' versus 'Time to Death'

P value = 0.000179 (logrank test), Q value = 8e-04

Table S328. Gene #78: 'del_12q23.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 27(12Q23.1) MUTATED	53	15	0.6 - 110.1 (21.9)
DEL PEAK 27(12Q23.1) WILD-TYPE	473	54	0.1 - 191.8 (23.5)

Figure S328. Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #1: 'Time to Death'

'del_12q23.1' versus 'YEARS_TO_BIRTH'

P value = 0.00236 (Wilcoxon-test), Q value = 0.0073

Table S329. Gene #78: 'del_12q23.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 27(12Q23.1) MUTATED	53	68.2 (9.5)
DEL PEAK 27(12Q23.1) WILD-TYPE	473	63.5 (11.3)

Figure S329. Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_12q23.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S330. Gene #78: 'del_12q23.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 27(12Q23.1) MUTATED	12	3	38
DEL PEAK 27(12Q23.1) WILD-TYPE	383	18	74

Figure S330. Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_12q23.1' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0491 (Fisher's exact test), Q value = 0.096

Table S331. Gene #78: 'del_12q23.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 27(12Q23.1) MUTATED	8	45
DEL PEAK 27(12Q23.1) WILD-TYPE	133	342

Figure S331. Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_12q23.1' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.041 (Fisher's exact test), Q value = 0.083

Table S332. Gene #78: 'del_12q23.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 27(12Q23.1) MUTATED	33	1	4	7
DEL PEAK 27(12Q23.1) WILD-TYPE	330	22	13	28

Figure S332. Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_12q23.1' versus 'RACE'

P value = 0.0413 (Fisher's exact test), Q value = 0.083

Table S333. Gene #78: 'del_12q23.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 27(12Q23.1) MUTATED	1	0	16	0	29
DEL PEAK 27(12Q23.1) WILD-TYPE	3	20	85	9	337

Figure S333. Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #6: 'RACE'

'del_12q24.33' versus 'Time to Death'

P value = 0.00562 (logrank test), Q value = 0.015

Table S334. Gene #79: 'del_12q24.33' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 28(12Q24.33) MUTATED	63	14	0.1 - 110.1 (20.8)
DEL PEAK 28(12Q24.33) WILD-TYPE	463	55	0.1 - 191.8 (23.6)

Figure S334. Get High-res Image Gene #79: 'del_12q24.33' versus Clinical Feature #1: 'Time to Death'

'del_12q24.33' versus 'YEARS_TO_BIRTH'

P value = 2.22e-05 (Wilcoxon-test), Q value = 0.00012

Table S335. Gene #79: 'del_12q24.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 28(12Q24.33) MUTATED	63	69.3 (8.7)
DEL PEAK 28(12Q24.33) WILD-TYPE	463	63.3 (11.3)

Figure S335. Get High-res Image Gene #79: 'del_12q24.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_12q24.33' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S336. Gene #79: 'del_12q24.33' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 28(12Q24.33) MUTATED	18	2	43
DEL PEAK 28(12Q24.33) WILD-TYPE	377	19	69

Figure S336. Get High-res Image Gene #79: 'del_12q24.33' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_12q24.33' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0219 (Fisher's exact test), Q value = 0.048

Table S337. Gene #79: 'del_12q24.33' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 28(12Q24.33) MUTATED	9	54
DEL PEAK 28(12Q24.33) WILD-TYPE	132	333

Figure S337. Get High-res Image Gene #79: 'del_12q24.33' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_12q24.33' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0267 (Fisher's exact test), Q value = 0.057

Table S338. Gene #79: 'del_12q24.33' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 28(12Q24.33) MUTATED	39	2	5	8
DEL PEAK 28(12Q24.33) WILD-TYPE	324	21	12	27

Figure S338. Get High-res Image Gene #79: 'del_12q24.33' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_13q11' versus 'Time to Death'

P value = 0.00311 (logrank test), Q value = 0.0093

Table S339. Gene #80: 'del_13q11' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 29(13Q11) MUTATED	93	22	0.1 - 149.6 (20.5)
DEL PEAK 29(13Q11) WILD-TYPE	433	47	0.1 - 191.8 (23.7)

Figure S339. Get High-res Image Gene #80: 'del_13q11' versus Clinical Feature #1: 'Time to Death'

'del_13q11' versus 'YEARS_TO_BIRTH'

P value = 0.00111 (Wilcoxon-test), Q value = 0.0039

Table S340. Gene #80: 'del_13q11' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 29(13Q11) MUTATED	93	67.2 (9.7)
DEL PEAK 29(13Q11) WILD-TYPE	433	63.3 (11.4)

Figure S340. Get High-res Image Gene #80: 'del_13q11' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_13q11' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S341. Gene #80: 'del_13q11' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 29(13Q11) MUTATED	39	5	50
DEL PEAK 29(13Q11) WILD-TYPE	356	16	62

Figure S341. Get High-res Image Gene #80: 'del_13q11' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_13q11' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0397 (Fisher's exact test), Q value = 0.081

Table S342. Gene #80: 'del_13q11' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 29(13Q11) MUTATED	17	77
DEL PEAK 29(13Q11) WILD-TYPE	124	310

Figure S342. Get High-res Image Gene #80: 'del_13q11' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_13q14.2' versus 'Time to Death'

P value = 0.00126 (logrank test), Q value = 0.0042

Table S343. Gene #81: 'del_13q14.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 30(13Q14.2) MUTATED	102	22	0.1 - 149.6 (20.3)
DEL PEAK 30(13Q14.2) WILD-TYPE	424	47	0.1 - 191.8 (23.9)

Figure S343. Get High-res Image Gene #81: 'del_13q14.2' versus Clinical Feature #1: 'Time to Death'

'del_13q14.2' versus 'YEARS_TO_BIRTH'

P value = 0.00137 (Wilcoxon-test), Q value = 0.0045

Table S344. Gene #81: 'del_13q14.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 30(13Q14.2) MUTATED	102	67.1 (9.5)
DEL PEAK 30(13Q14.2) WILD-TYPE	424	63.3 (11.5)

Figure S344. Get High-res Image Gene #81: 'del_13q14.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_13q14.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S345. Gene #81: 'del_13q14.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 30(13Q14.2) MUTATED	51	6	46
DEL PEAK 30(13Q14.2) WILD-TYPE	344	15	66

Figure S345. Get High-res Image Gene #81: 'del_13q14.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_13q14.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.009 (Fisher's exact test), Q value = 0.022

Table S346. Gene #81: 'del_13q14.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 30(13Q14.2) MUTATED	17	86
DEL PEAK 30(13Q14.2) WILD-TYPE	124	301

Figure S346. Get High-res Image Gene #81: 'del_13q14.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_13q14.2' versus 'RACE'

P value = 0.154 (Fisher's exact test), Q value = 0.24

Table S347. Gene #81: 'del_13q14.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 30(13Q14.2) MUTATED	0	2	28	2	66
DEL PEAK 30(13Q14.2) WILD-TYPE	4	18	73	7	300

Figure S347. Get High-res Image Gene #81: 'del_13q14.2' versus Clinical Feature #6: 'RACE'

'del_14q13.1' versus 'Time to Death'

P value = 0.00804 (logrank test), Q value = 0.02

Table S348. Gene #82: 'del_14q13.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 31(14Q13.1) MUTATED	71	14	0.1 - 125.4 (17.9)
DEL PEAK 31(14Q13.1) WILD-TYPE	455	55	0.1 - 191.8 (23.9)

Figure S348. Get High-res Image Gene #82: 'del_14q13.1' versus Clinical Feature #1: 'Time to Death'

'del_14q13.1' versus 'YEARS_TO_BIRTH'

P value = 0.00402 (Wilcoxon-test), Q value = 0.012

Table S349. Gene #82: 'del_14q13.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 31(14Q13.1) MUTATED	71	67.2 (9.9)
DEL PEAK 31(14Q13.1) WILD-TYPE	455	63.5 (11.3)

Figure S349. Get High-res Image Gene #82: 'del_14q13.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_14q13.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S350. Gene #82: 'del_14q13.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 31(14Q13.1) MUTATED	25	5	41
DEL PEAK 31(14Q13.1) WILD-TYPE	370	16	71

Figure S350. Get High-res Image Gene #82: 'del_14q13.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_14q13.1' versus 'RACE'

P value = 0.00394 (Fisher's exact test), Q value = 0.011

Table S351. Gene #82: 'del_14q13.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 31(14Q13.1) MUTATED	1	1	25	1	38
DEL PEAK 31(14Q13.1) WILD-TYPE	3	19	76	8	328

Figure S351. Get High-res Image Gene #82: 'del_14q13.1' versus Clinical Feature #6: 'RACE'

'del_15q15.1' versus 'Time to Death'

P value = 7.04e-05 (logrank test), Q value = 0.00036

Table S352. Gene #83: 'del_15q15.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 32(15Q15.1) MUTATED	135	30	0.1 - 116.2 (20.8)
DEL PEAK 32(15Q15.1) WILD-TYPE	391	39	0.1 - 191.8 (23.9)

Figure S352. Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #1: 'Time to Death'

'del_15q15.1' versus 'YEARS_TO_BIRTH'

P value = 2.37e-08 (Wilcoxon-test), Q value = 1.4e-06

Table S353. Gene #83: 'del_15q15.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 32(15Q15.1) MUTATED	136	68.4 (9.6)
DEL PEAK 32(15Q15.1) WILD-TYPE	390	62.5 (11.4)

Figure S353. Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_15q15.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S354. Gene #83: 'del_15q15.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 32(15Q15.1) MUTATED	52	9	75
DEL PEAK 32(15Q15.1) WILD-TYPE	343	12	37

Figure S354. Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_15q15.1' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0131 (Fisher's exact test), Q value = 0.031

Table S355. Gene #83: 'del_15q15.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 32(15Q15.1) MUTATED	25	111
DEL PEAK 32(15Q15.1) WILD-TYPE	116	276

Figure S355. Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_15q15.1' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0396 (Fisher's exact test), Q value = 0.081

Table S356. Gene #83: 'del_15q15.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 32(15Q15.1) MUTATED	83	7	8	13
DEL PEAK 32(15Q15.1) WILD-TYPE	280	16	9	22

Figure S356. Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_15q15.1' versus 'RACE'

P value = 0.0549 (Fisher's exact test), Q value = 0.11

Table S357. Gene #83: 'del_15q15.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 32(15Q15.1) MUTATED	1	2	35	3	84
DEL PEAK 32(15Q15.1) WILD-TYPE	3	18	66	6	282

Figure S357. Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #6: 'RACE'

'del_15q23' versus 'Time to Death'

P value = 0.0119 (logrank test), Q value = 0.029

Table S358. Gene #84: 'del_15q23' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 33(15Q23) MUTATED	113	21	0.2 - 125.4 (19.4)
DEL PEAK 33(15Q23) WILD-TYPE	413	48	0.1 - 191.8 (24.6)

Figure S358. Get High-res Image Gene #84: 'del_15q23' versus Clinical Feature #1: 'Time to Death'

'del_15q23' versus 'YEARS_TO_BIRTH'

P value = 8.57e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S359. Gene #84: 'del_15q23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 33(15Q23) MUTATED	113	67.8 (9.4)
DEL PEAK 33(15Q23) WILD-TYPE	413	63.0 (11.5)

Figure S359. Get High-res Image Gene #84: 'del_15q23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_15q23' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S360. Gene #84: 'del_15q23' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 33(15Q23) MUTATED	38	7	68
DEL PEAK 33(15Q23) WILD-TYPE	357	14	44

Figure S360. Get High-res Image Gene #84: 'del_15q23' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_15q23' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0551 (Fisher's exact test), Q value = 0.11

Table S361. Gene #84: 'del_15q23' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 33(15Q23) MUTATED	22	91
DEL PEAK 33(15Q23) WILD-TYPE	119	296

Figure S361. Get High-res Image Gene #84: 'del_15q23' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_15q23' versus 'RACE'

P value = 0.0338 (Fisher's exact test), Q value = 0.069

Table S362. Gene #84: 'del_15q23' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 33(15Q23) MUTATED	0	2	32	1	68
DEL PEAK 33(15Q23) WILD-TYPE	4	18	69	8	298

Figure S362. Get High-res Image Gene #84: 'del_15q23' versus Clinical Feature #6: 'RACE'

'del_16p13.3' versus 'Time to Death'

P value = 0.00536 (logrank test), Q value = 0.014

Table S363. Gene #85: 'del_16p13.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 34(16P13.3) MUTATED	89	19	0.1 - 125.4 (21.9)
DEL PEAK 34(16P13.3) WILD-TYPE	437	50	0.1 - 191.8 (23.5)

Figure S363. Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #1: 'Time to Death'

'del_16p13.3' versus 'YEARS_TO_BIRTH'

P value = 2.2e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S364. Gene #85: 'del_16p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 34(16P13.3) MUTATED	90	68.9 (8.6)
DEL PEAK 34(16P13.3) WILD-TYPE	436	63.0 (11.4)

Figure S364. Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_16p13.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S365. Gene #85: 'del_16p13.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 34(16P13.3) MUTATED	26	5	59
DEL PEAK 34(16P13.3) WILD-TYPE	369	16	53

Figure S365. Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_16p13.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0682 (Fisher's exact test), Q value = 0.13

Table S366. Gene #85: 'del_16p13.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 34(16P13.3) MUTATED	17	73
DEL PEAK 34(16P13.3) WILD-TYPE	124	314

Figure S366. Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_16p13.3' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.105 (Fisher's exact test), Q value = 0.18

Table S367. Gene #85: 'del_16p13.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 34(16P13.3) MUTATED	53	6	5	8
DEL PEAK 34(16P13.3) WILD-TYPE	310	17	12	27

Figure S367. Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_16p13.3' versus 'RACE'

P value = 0.0297 (Fisher's exact test), Q value = 0.062

Table S368. Gene #85: 'del_16p13.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 34(16P13.3) MUTATED	0	2	28	1	53
DEL PEAK 34(16P13.3) WILD-TYPE	4	18	73	8	313

Figure S368. Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #6: 'RACE'

'del_16q21' versus 'Time to Death'

P value = 0.00957 (logrank test), Q value = 0.024

Table S369. Gene #86: 'del_16q21' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 35(16Q21) MUTATED	149	27	0.1 - 113.4 (22.0)
DEL PEAK 35(16Q21) WILD-TYPE	377	42	0.1 - 191.8 (23.6)

Figure S369. Get High-res Image Gene #86: 'del_16q21' versus Clinical Feature #1: 'Time to Death'

'del_16q21' versus 'YEARS_TO_BIRTH'

P value = 1.31e-08 (Wilcoxon-test), Q value = 1e-06

Table S370. Gene #86: 'del_16q21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 35(16Q21) MUTATED	150	68.1 (9.1)
DEL PEAK 35(16Q21) WILD-TYPE	376	62.4 (11.6)

Figure S370. Get High-res Image Gene #86: 'del_16q21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_16q21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S371. Gene #86: 'del_16q21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 35(16Q21) MUTATED	63	8	79
DEL PEAK 35(16Q21) WILD-TYPE	332	13	33

Figure S371. Get High-res Image Gene #86: 'del_16q21' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_16q21' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.082 (Fisher's exact test), Q value = 0.15

Table S372. Gene #86: 'del_16q21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 35(16Q21) MUTATED	32	118
DEL PEAK 35(16Q21) WILD-TYPE	109	269

Figure S372. Get High-res Image Gene #86: 'del_16q21' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_16q21' versus 'RACE'

P value = 0.0232 (Fisher's exact test), Q value = 0.051

Table S373. Gene #86: 'del_16q21' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 35(16Q21) MUTATED	1	2	40	2	95
DEL PEAK 35(16Q21) WILD-TYPE	3	18	61	7	271

Figure S373. Get High-res Image Gene #86: 'del_16q21' versus Clinical Feature #6: 'RACE'

'del_16q22.3' versus 'Time to Death'

P value = 0.0289 (logrank test), Q value = 0.061

Table S374. Gene #87: 'del_16q22.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 36(16Q22.3) MUTATED	153	26	0.1 - 113.4 (20.8)
DEL PEAK 36(16Q22.3) WILD-TYPE	373	43	0.1 - 191.8 (23.9)

Figure S374. Get High-res Image Gene #87: 'del_16q22.3' versus Clinical Feature #1: 'Time to Death'

'del_16q22.3' versus 'YEARS_TO_BIRTH'

P value = 5.81e-09 (Wilcoxon-test), Q value = 6.8e-07

Table S375. Gene #87: 'del_16q22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 36(16Q22.3) MUTATED	154	68.0 (8.9)
DEL PEAK 36(16Q22.3) WILD-TYPE	372	62.3 (11.6)

Figure S375. Get High-res Image Gene #87: 'del_16q22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_16q22.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S376. Gene #87: 'del_16q22.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 36(16Q22.3) MUTATED	67	8	79
DEL PEAK 36(16Q22.3) WILD-TYPE	328	13	33

Figure S376. Get High-res Image Gene #87: 'del_16q22.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_16q22.3' versus 'RACE'

P value = 0.0323 (Fisher's exact test), Q value = 0.066

Table S377. Gene #87: 'del_16q22.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 36(16Q22.3) MUTATED	1	2	40	2	98
DEL PEAK 36(16Q22.3) WILD-TYPE	3	18	61	7	268

Figure S377. Get High-res Image Gene #87: 'del_16q22.3' versus Clinical Feature #6: 'RACE'

'del_16q23.1' versus 'Time to Death'

P value = 0.00282 (logrank test), Q value = 0.0085

Table S378. Gene #88: 'del_16q23.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 37(16Q23.1) MUTATED	161	30	0.1 - 113.4 (21.2)
DEL PEAK 37(16Q23.1) WILD-TYPE	365	39	0.1 - 191.8 (23.9)

Figure S378. Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #1: 'Time to Death'

'del_16q23.1' versus 'YEARS_TO_BIRTH'

P value = 8.79e-09 (Wilcoxon-test), Q value = 8.8e-07

Table S379. Gene #88: 'del_16q23.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 37(16Q23.1) MUTATED	162	67.8 (9.3)
DEL PEAK 37(16Q23.1) WILD-TYPE	364	62.3 (11.6)

Figure S379. Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_16q23.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S380. Gene #88: 'del_16q23.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 37(16Q23.1) MUTATED	69	7	86
DEL PEAK 37(16Q23.1) WILD-TYPE	326	14	26

Figure S380. Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_16q23.1' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0173 (Fisher's exact test), Q value = 0.039

Table S381. Gene #88: 'del_16q23.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 37(16Q23.1) MUTATED	102	8	11	12
DEL PEAK 37(16Q23.1) WILD-TYPE	261	15	6	23

Figure S381. Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_16q23.1' versus 'RACE'

P value = 0.00318 (Fisher's exact test), Q value = 0.0094

Table S382. Gene #88: 'del_16q23.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 37(16Q23.1) MUTATED	1	3	46	2	99
DEL PEAK 37(16Q23.1) WILD-TYPE	3	17	55	7	267

Figure S382. Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #6: 'RACE'

'del_17p13.3' versus 'Time to Death'

P value = 0.000112 (logrank test), Q value = 0.00052

Table S383. Gene #89: 'del_17p13.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 38(17P13.3) MUTATED	118	27	0.1 - 125.4 (20.6)
DEL PEAK 38(17P13.3) WILD-TYPE	408	42	0.1 - 191.8 (23.9)

Figure S383. Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #1: 'Time to Death'

'del_17p13.3' versus 'YEARS_TO_BIRTH'

P value = 0.000232 (Wilcoxon-test), Q value = 0.00097

Table S384. Gene #89: 'del_17p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 38(17P13.3) MUTATED	118	67.0 (9.0)
DEL PEAK 38(17P13.3) WILD-TYPE	408	63.1 (11.6)

Figure S384. Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_17p13.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S385. Gene #89: 'del_17p13.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 38(17P13.3) MUTATED	46	9	64
DEL PEAK 38(17P13.3) WILD-TYPE	349	12	48

Figure S385. Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_17p13.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0451 (Fisher's exact test), Q value = 0.089

Table S386. Gene #89: 'del_17p13.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 38(17P13.3) MUTATED	23	96
DEL PEAK 38(17P13.3) WILD-TYPE	118	291

Figure S386. Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_17p13.3' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.146 (Fisher's exact test), Q value = 0.23

Table S387. Gene #89: 'del_17p13.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 38(17P13.3) MUTATED	72	7	4	12
DEL PEAK 38(17P13.3) WILD-TYPE	291	16	13	23

Figure S387. Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_17p13.3' versus 'RACE'

P value = 0.00155 (Fisher's exact test), Q value = 0.0051

Table S388. Gene #89: 'del_17p13.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 38(17P13.3) MUTATED	0	2	37	3	69
DEL PEAK 38(17P13.3) WILD-TYPE	4	18	64	6	297

Figure S388. Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #6: 'RACE'

'del_17p11.2' versus 'Time to Death'

P value = 0.000381 (logrank test), Q value = 0.0015

Table S389. Gene #90: 'del_17p11.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 39(17P11.2) MUTATED	123	27	0.1 - 125.4 (20.5)
DEL PEAK 39(17P11.2) WILD-TYPE	403	42	0.1 - 191.8 (23.9)

Figure S389. Get High-res Image Gene #90: 'del_17p11.2' versus Clinical Feature #1: 'Time to Death'

'del_17p11.2' versus 'YEARS_TO_BIRTH'

P value = 4.49e-06 (Wilcoxon-test), Q value = 5.9e-05

Table S390. Gene #90: 'del_17p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 39(17P11.2) MUTATED	123	67.7 (9.3)
DEL PEAK 39(17P11.2) WILD-TYPE	403	62.9 (11.5)

Figure S390. Get High-res Image Gene #90: 'del_17p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_17p11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S391. Gene #90: 'del_17p11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 39(17P11.2) MUTATED	45	8	71
DEL PEAK 39(17P11.2) WILD-TYPE	350	13	41

Figure S391. Get High-res Image Gene #90: 'del_17p11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_17p11.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.105 (Fisher's exact test), Q value = 0.18

Table S392. Gene #90: 'del_17p11.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 39(17P11.2) MUTATED	26	98
DEL PEAK 39(17P11.2) WILD-TYPE	115	289

Figure S392. Get High-res Image Gene #90: 'del_17p11.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_17p11.2' versus 'RACE'

P value = 0.0125 (Fisher's exact test), Q value = 0.03

Table S393. Gene #90: 'del_17p11.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 39(17P11.2) MUTATED	0	2	36	1	77
DEL PEAK 39(17P11.2) WILD-TYPE	4	18	65	8	289

Figure S393. Get High-res Image Gene #90: 'del_17p11.2' versus Clinical Feature #6: 'RACE'

'del_17q11.2' versus 'Time to Death'

P value = 0.0291 (logrank test), Q value = 0.061

Table S394. Gene #91: 'del_17q11.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 40(17Q11.2) MUTATED	100	20	0.2 - 125.4 (22.3)
DEL PEAK 40(17Q11.2) WILD-TYPE	426	49	0.1 - 191.8 (23.4)

Figure S394. Get High-res Image Gene #91: 'del_17q11.2' versus Clinical Feature #1: 'Time to Death'

'del_17q11.2' versus 'YEARS_TO_BIRTH'

P value = 8.58e-07 (Wilcoxon-test), Q value = 2.7e-05

Table S395. Gene #91: 'del_17q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 40(17Q11.2) MUTATED	101	68.3 (9.4)
DEL PEAK 40(17Q11.2) WILD-TYPE	425	63.0 (11.4)

Figure S395. Get High-res Image Gene #91: 'del_17q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_17q11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S396. Gene #91: 'del_17q11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 40(17Q11.2) MUTATED	43	5	53
DEL PEAK 40(17Q11.2) WILD-TYPE	352	16	59

Figure S396. Get High-res Image Gene #91: 'del_17q11.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_17q21.31' versus 'Time to Death'

P value = 0.000198 (logrank test), Q value = 0.00086

Table S397. Gene #92: 'del_17q21.31' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 41(17Q21.31) MUTATED	108	26	0.2 - 125.4 (22.3)
DEL PEAK 41(17Q21.31) WILD-TYPE	418	43	0.1 - 191.8 (23.4)

Figure S397. Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #1: 'Time to Death'

'del_17q21.31' versus 'YEARS_TO_BIRTH'

P value = 1.18e-05 (Wilcoxon-test), Q value = 6.9e-05

Table S398. Gene #92: 'del_17q21.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 41(17Q21.31) MUTATED	108	67.9 (9.7)
DEL PEAK 41(17Q21.31) WILD-TYPE	418	63.0 (11.4)

Figure S398. Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_17q21.31' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S399. Gene #92: 'del_17q21.31' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 41(17Q21.31) MUTATED	44	5	60
DEL PEAK 41(17Q21.31) WILD-TYPE	351	16	52

Figure S399. Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_17q21.31' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0522 (Fisher's exact test), Q value = 0.1

Table S400. Gene #92: 'del_17q21.31' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 41(17Q21.31) MUTATED	21	88
DEL PEAK 41(17Q21.31) WILD-TYPE	120	299

Figure S400. Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_17q21.31' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0707 (Fisher's exact test), Q value = 0.13

Table S401. Gene #92: 'del_17q21.31' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 41(17Q21.31) MUTATED	66	6	6	11
DEL PEAK 41(17Q21.31) WILD-TYPE	297	17	11	24

Figure S401. Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_17q21.31' versus 'ETHNICITY'

P value = 0.0481 (Fisher's exact test), Q value = 0.094

Table S402. Gene #92: 'del_17q21.31' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	14	367
DEL PEAK 41(17Q21.31) MUTATED	6	73
DEL PEAK 41(17Q21.31) WILD-TYPE	8	294

Figure S402. Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #7: 'ETHNICITY'

'del_18q21.2' versus 'YEARS_TO_BIRTH'

P value = 3e-04 (Wilcoxon-test), Q value = 0.0012

Table S403. Gene #93: 'del_18q21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 42(18Q21.2) MUTATED	89	67.6 (9.8)
DEL PEAK 42(18Q21.2) WILD-TYPE	437	63.3 (11.4)

Figure S403. Get High-res Image Gene #93: 'del_18q21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_18q21.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S404. Gene #93: 'del_18q21.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 42(18Q21.2) MUTATED	37	6	46
DEL PEAK 42(18Q21.2) WILD-TYPE	358	15	66

Figure S404. Get High-res Image Gene #93: 'del_18q21.2' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_18q21.2' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.00383 (Fisher's exact test), Q value = 0.011

Table S405. Gene #93: 'del_18q21.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 42(18Q21.2) MUTATED	13	76
DEL PEAK 42(18Q21.2) WILD-TYPE	128	311

Figure S405. Get High-res Image Gene #93: 'del_18q21.2' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_18q21.2' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.129 (Fisher's exact test), Q value = 0.21

Table S406. Gene #93: 'del_18q21.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 42(18Q21.2) MUTATED	51	5	5	8
DEL PEAK 42(18Q21.2) WILD-TYPE	312	18	12	27

Figure S406. Get High-res Image Gene #93: 'del_18q21.2' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_18q21.2' versus 'RACE'

P value = 0.0696 (Fisher's exact test), Q value = 0.13

Table S407. Gene #93: 'del_18q21.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 42(18Q21.2) MUTATED	0	2	25	3	54
DEL PEAK 42(18Q21.2) WILD-TYPE	4	18	76	6	312

Figure S407. Get High-res Image Gene #93: 'del_18q21.2' versus Clinical Feature #6: 'RACE'

'del_18q23' versus 'Time to Death'

P value = 0.0051 (logrank test), Q value = 0.014

Table S408. Gene #94: 'del_18q23' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 43(18Q23) MUTATED	94	19	0.1 - 116.2 (20.0)
DEL PEAK 43(18Q23) WILD-TYPE	432	50	0.1 - 191.8 (23.9)

Figure S408. Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #1: 'Time to Death'

'del_18q23' versus 'YEARS_TO_BIRTH'

P value = 0.000443 (Wilcoxon-test), Q value = 0.0017

Table S409. Gene #94: 'del_18q23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 43(18Q23) MUTATED	94	67.5 (10.2)
DEL PEAK 43(18Q23) WILD-TYPE	432	63.2 (11.3)

Figure S409. Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_18q23' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S410. Gene #94: 'del_18q23' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 43(18Q23) MUTATED	37	6	52
DEL PEAK 43(18Q23) WILD-TYPE	358	15	60

Figure S410. Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_18q23' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.000482 (Fisher's exact test), Q value = 0.0018

Table S411. Gene #94: 'del_18q23' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 43(18Q23) MUTATED	12	83
DEL PEAK 43(18Q23) WILD-TYPE	129	304

Figure S411. Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_18q23' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0122 (Fisher's exact test), Q value = 0.029

Table S412. Gene #94: 'del_18q23' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 43(18Q23) MUTATED	56	5	8	7
DEL PEAK 43(18Q23) WILD-TYPE	307	18	9	28

Figure S412. Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_18q23' versus 'RACE'

P value = 0.0608 (Fisher's exact test), Q value = 0.11

Table S413. Gene #94: 'del_18q23' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 43(18Q23) MUTATED	1	2	26	3	57
DEL PEAK 43(18Q23) WILD-TYPE	3	18	75	6	309

Figure S413. Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #6: 'RACE'

'del_18q23' versus 'ETHNICITY'

P value = 0.149 (Fisher's exact test), Q value = 0.24

Table S414. Gene #94: 'del_18q23' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	14	367
DEL PEAK 43(18Q23) MUTATED	5	65
DEL PEAK 43(18Q23) WILD-TYPE	9	302

Figure S414. Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #7: 'ETHNICITY'

'del_19p13.3' versus 'Time to Death'

P value = 7.09e-06 (logrank test), Q value = 5.9e-05

Table S415. Gene #95: 'del_19p13.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 44(19P13.3) MUTATED	150	35	0.1 - 125.4 (21.9)
DEL PEAK 44(19P13.3) WILD-TYPE	376	34	0.1 - 191.8 (23.8)

Figure S415. Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #1: 'Time to Death'

'del_19p13.3' versus 'YEARS_TO_BIRTH'

P value = 1.35e-10 (Wilcoxon-test), Q value = 4.7e-08

Table S416. Gene #95: 'del_19p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 44(19P13.3) MUTATED	150	68.6 (8.6)
DEL PEAK 44(19P13.3) WILD-TYPE	376	62.2 (11.6)

Figure S416. Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_19p13.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S417. Gene #95: 'del_19p13.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 44(19P13.3) MUTATED	45	8	98
DEL PEAK 44(19P13.3) WILD-TYPE	350	13	14

Figure S417. Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_19p13.3' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0815 (Fisher's exact test), Q value = 0.15

Table S418. Gene #95: 'del_19p13.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 44(19P13.3) MUTATED	32	119
DEL PEAK 44(19P13.3) WILD-TYPE	109	268

Figure S418. Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_19p13.3' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.00614 (Fisher's exact test), Q value = 0.016

Table S419. Gene #95: 'del_19p13.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 44(19P13.3) MUTATED	90	9	9	15
DEL PEAK 44(19P13.3) WILD-TYPE	273	14	8	20

Figure S419. Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_19p13.3' versus 'RACE'

P value = 0.00027 (Fisher's exact test), Q value = 0.0011

Table S420. Gene #95: 'del_19p13.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 44(19P13.3) MUTATED	1	2	46	3	90
DEL PEAK 44(19P13.3) WILD-TYPE	3	18	55	6	276

Figure S420. Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #6: 'RACE'

'del_19p12' versus 'Time to Death'

P value = 0.0869 (logrank test), Q value = 0.16

Table S421. Gene #96: 'del_19p12' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 45(19P12) MUTATED	57	12	0.2 - 116.2 (24.0)
DEL PEAK 45(19P12) WILD-TYPE	469	57	0.1 - 191.8 (23.3)

Figure S421. Get High-res Image Gene #96: 'del_19p12' versus Clinical Feature #1: 'Time to Death'

'del_19p12' versus 'YEARS_TO_BIRTH'

P value = 0.0143 (Wilcoxon-test), Q value = 0.033

Table S422. Gene #96: 'del_19p12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 45(19P12) MUTATED	56	67.2 (9.7)
DEL PEAK 45(19P12) WILD-TYPE	470	63.6 (11.3)

Figure S422. Get High-res Image Gene #96: 'del_19p12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_19p12' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S423. Gene #96: 'del_19p12' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 45(19P12) MUTATED	20	5	32
DEL PEAK 45(19P12) WILD-TYPE	375	16	80

Figure S423. Get High-res Image Gene #96: 'del_19p12' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_19p12' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0256 (Fisher's exact test), Q value = 0.055

Table S424. Gene #96: 'del_19p12' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 45(19P12) MUTATED	8	49
DEL PEAK 45(19P12) WILD-TYPE	133	338

Figure S424. Get High-res Image Gene #96: 'del_19p12' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_19p12' versus 'RACE'

P value = 0.126 (Fisher's exact test), Q value = 0.21

Table S425. Gene #96: 'del_19p12' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 45(19P12) MUTATED	1	1	17	1	34
DEL PEAK 45(19P12) WILD-TYPE	3	19	84	8	332

Figure S425. Get High-res Image Gene #96: 'del_19p12' versus Clinical Feature #6: 'RACE'

'del_19q13.43' versus 'Time to Death'

P value = 0.00191 (logrank test), Q value = 0.0061

Table S426. Gene #97: 'del_19q13.43' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 46(19Q13.43) MUTATED	64	16	0.1 - 125.4 (21.9)
DEL PEAK 46(19Q13.43) WILD-TYPE	462	53	0.1 - 191.8 (23.4)

Figure S426. Get High-res Image Gene #97: 'del_19q13.43' versus Clinical Feature #1: 'Time to Death'

'del_19q13.43' versus 'YEARS_TO_BIRTH'

P value = 0.000307 (Wilcoxon-test), Q value = 0.0012

Table S427. Gene #97: 'del_19q13.43' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 46(19Q13.43) MUTATED	64	68.3 (9.7)
DEL PEAK 46(19Q13.43) WILD-TYPE	462	63.4 (11.3)

Figure S427. Get High-res Image Gene #97: 'del_19q13.43' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_19q13.43' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S428. Gene #97: 'del_19q13.43' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 46(19Q13.43) MUTATED	19	4	42
DEL PEAK 46(19Q13.43) WILD-TYPE	376	17	70

Figure S428. Get High-res Image Gene #97: 'del_19q13.43' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_19q13.43' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.0255 (Fisher's exact test), Q value = 0.055

Table S429. Gene #97: 'del_19q13.43' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 46(19Q13.43) MUTATED	36	6	3	7
DEL PEAK 46(19Q13.43) WILD-TYPE	327	17	14	28

Figure S429. Get High-res Image Gene #97: 'del_19q13.43' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_20p12.1' versus 'Time to Death'

P value = 8.85e-05 (logrank test), Q value = 0.00043

Table S430. Gene #98: 'del_20p12.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 47(20P12.1) MUTATED	35	13	0.3 - 149.6 (21.9)
DEL PEAK 47(20P12.1) WILD-TYPE	491	56	0.1 - 191.8 (23.4)

Figure S430. Get High-res Image Gene #98: 'del_20p12.1' versus Clinical Feature #1: 'Time to Death'

'del_20p12.1' versus 'YEARS_TO_BIRTH'

P value = 0.14 (Wilcoxon-test), Q value = 0.23

Table S431. Gene #98: 'del_20p12.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 47(20P12.1) MUTATED	34	66.9 (10.4)
DEL PEAK 47(20P12.1) WILD-TYPE	492	63.8 (11.3)

Figure S431. Get High-res Image Gene #98: 'del_20p12.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_20p12.1' versus 'HISTOLOGICAL_TYPE'

P value = 2e-04 (Fisher's exact test), Q value = 0.00086

Table S432. Gene #98: 'del_20p12.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 47(20P12.1) MUTATED	16	2	17
DEL PEAK 47(20P12.1) WILD-TYPE	379	19	95

Figure S432. Get High-res Image Gene #98: 'del_20p12.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_20p12.1' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.106 (Fisher's exact test), Q value = 0.18

Table S433. Gene #98: 'del_20p12.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 47(20P12.1) MUTATED	20	1	2	5
DEL PEAK 47(20P12.1) WILD-TYPE	343	22	15	30

Figure S433. Get High-res Image Gene #98: 'del_20p12.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_22q13.32' versus 'Time to Death'

P value = 0.000218 (logrank test), Q value = 0.00092

Table S434. Gene #99: 'del_22q13.32' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 48(22Q13.32) MUTATED	135	28	0.1 - 116.2 (20.0)
DEL PEAK 48(22Q13.32) WILD-TYPE	391	41	0.1 - 191.8 (24.3)

Figure S434. Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #1: 'Time to Death'

'del_22q13.32' versus 'YEARS_TO_BIRTH'

P value = 1.05e-07 (Wilcoxon-test), Q value = 4.6e-06

Table S435. Gene #99: 'del_22q13.32' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 48(22Q13.32) MUTATED	135	68.4 (9.5)
DEL PEAK 48(22Q13.32) WILD-TYPE	391	62.5 (11.4)

Figure S435. Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_22q13.32' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S436. Gene #99: 'del_22q13.32' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 48(22Q13.32) MUTATED	54	10	72
DEL PEAK 48(22Q13.32) WILD-TYPE	341	11	40

Figure S436. Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_22q13.32' versus 'RADIATIONS_RADIATION_REGIMENINDICATION'

P value = 0.0242 (Fisher's exact test), Q value = 0.053

Table S437. Gene #99: 'del_22q13.32' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

nPatients	NO	YES
ALL	141	387
DEL PEAK 48(22Q13.32) MUTATED	26	110
DEL PEAK 48(22Q13.32) WILD-TYPE	115	277

Figure S437. Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #4: 'RADIATIONS_RADIATION_REGIMENINDICATION'

'del_22q13.32' versus 'RACE'

P value = 0.0157 (Fisher's exact test), Q value = 0.036

Table S438. Gene #99: 'del_22q13.32' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 48(22Q13.32) MUTATED	1	1	37	2	89
DEL PEAK 48(22Q13.32) WILD-TYPE	3	19	64	7	277

Figure S438. Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #6: 'RACE'

'del_xp21.1' versus 'Time to Death'

P value = 1.97e-05 (logrank test), Q value = 0.00011

Table S439. Gene #100: 'del_xp21.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	526	69	0.1 - 191.8 (23.3)
DEL PEAK 49(XP21.1) MUTATED	83	23	0.3 - 113.4 (20.1)
DEL PEAK 49(XP21.1) WILD-TYPE	443	46	0.1 - 191.8 (23.5)

Figure S439. Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #1: 'Time to Death'

'del_xp21.1' versus 'YEARS_TO_BIRTH'

P value = 0.000139 (Wilcoxon-test), Q value = 0.00064

Table S440. Gene #100: 'del_xp21.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	526	64.0 (11.2)
DEL PEAK 49(XP21.1) MUTATED	83	68.1 (9.3)
DEL PEAK 49(XP21.1) WILD-TYPE	443	63.2 (11.4)

Figure S440. Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_xp21.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.9e-05

Table S441. Gene #100: 'del_xp21.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	395	21	112
DEL PEAK 49(XP21.1) MUTATED	31	3	50
DEL PEAK 49(XP21.1) WILD-TYPE	364	18	62

Figure S441. Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #3: 'HISTOLOGICAL_TYPE'

'del_xp21.1' versus 'COMPLETENESS_OF_RESECTION'

P value = 0.125 (Fisher's exact test), Q value = 0.21

Table S442. Gene #100: 'del_xp21.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

nPatients	R0	R1	R2	RX
ALL	363	23	17	35
DEL PEAK 49(XP21.1) MUTATED	53	2	6	6
DEL PEAK 49(XP21.1) WILD-TYPE	310	21	11	29

Figure S442. Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #5: 'COMPLETENESS_OF_RESECTION'

'del_xp21.1' versus 'RACE'

P value = 0.00411 (Fisher's exact test), Q value = 0.012

Table S443. Gene #100: 'del_xp21.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	101	9	366
DEL PEAK 49(XP21.1) MUTATED	1	1	28	1	47
DEL PEAK 49(XP21.1) WILD-TYPE	3	19	73	8	319

Figure S443. Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #6: 'RACE'

Methods & Data

Input

Copy number data file = all_lesions.txt from GISTIC pipeline
Processed Copy number data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_Correlate_Genomic_Events_Preprocess/UCEC-TP/15106279/transformed.cor.cli.txt
Clinical data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/Append_Data/UCEC-TP/15094079/UCEC-TP.merged_data.txt
Number of patients = 528
Number of significantly focal cnvs = 100
Number of selected clinical features = 7
Exclude genes that fewer than K tumors have mutations, K = 3

Survival analysis

For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R

Fisher's exact test

For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

References

[1] Bland and Altman, Statistics notes: The logrank test, BMJ 328(7447):1073 (2004)

[2] Fisher, R.A., On the interpretation of chi-square from contingency tables, and the calculation of P, Journal of the Royal Statistical Society 85(1):87-94 (1922)

[3] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)

Made with Nozzle